<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id><journal-title-group><journal-title>BMC Genomics</journal-title></journal-title-group><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4246558</article-id><article-id pub-id-type="pmid">25407019</article-id><article-id pub-id-type="publisher-id">6671</article-id><article-id pub-id-type="doi">10.1186/1471-2164-15-982</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Retinal transcriptome profiling at transcription start sites: a cap analysis of gene expression early after axonal injury</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yasuda</surname><given-names>Masayuki</given-names></name><address><email>myasuda@oph.med.tohoku.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Tanaka</surname><given-names>Yuji</given-names></name><address><email>ytanaka@oph.med.tohoku.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Nishiguchi</surname><given-names>Koji M</given-names></name><address><email>nishiguchi@oph.med.tohoku.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Ryu</surname><given-names>Morin</given-names></name><address><email>ryu@oph.med.tohoku.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Tsuda</surname><given-names>Satoru</given-names></name><address><email>tsuda@oph.med.tohoku.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Maruyama</surname><given-names>Kazuichi</given-names></name><address><email>maruyama-k@oph.med.tohoku.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Nakazawa</surname><given-names>Toru</given-names></name><address><email>ntoru@oph.med.tohoku.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/><xref ref-type="aff" rid="Aff4"/><xref ref-type="aff" rid="Aff5"/></contrib><aff id="Aff3"><label/>Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574 Japan </aff><aff id="Aff4"><label/>Department of Retinal Disease Control, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574 Japan </aff><aff id="Aff5"><label/>Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574 Japan </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>15</volume><issue>1</issue><elocation-id>982</elocation-id><history><date date-type="received"><day>28</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>23</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; Yasuda et al.; licensee BioMed Central Ltd. 2014</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Glaucoma is characterized by progressive loss of the visual field and death of retinal ganglion cells (RGCs), a process that is mediated, in part, by axonal injury. However, the molecular pathomechanisms linking RGC death and axonal injury remain largely unknown. Here, we examined these mechanisms with a cap analysis of gene expression (CAGE), which allows the comprehensive quantification of transcription initiation across the entire genome. We aimed to identify changes in gene expression patterns and to predict the resulting alterations in the protein network in the early phases of axonal injury in mice.</p></sec><sec><title>Results</title><p>We performed optic nerve crush (ONC) in mice to model axonal injury. Two days after ONC, the retinas were isolated, RNA was extracted, and a CAGE library was constructed and sequenced. CAGE data for ONC eyes and sham-treated eyes was compared, revealing 180 differentially expressed genes. Among them, the <italic>Bcat1</italic> gene, involved in the catabolism of branched-chain amino acid transaminase, showed the largest change in expression (log2 fold-change =&#x02009;6.70). In some differentially expressed genes, alternative transcription start sites were observed in the ONC eyes, highlighting the dynamism of transcription initiation in a state of disease. <italic>In silico</italic> pathway analysis predicted that ATF4 was the most significant upstream regulator orchestrating pathological processes after ONC. Its downstream candidate targets included <italic>Ddit3,</italic> which is known to induce cell death under endoplasmic reticulum stress. In addition, a regulatory network comprising IFNG, P38 MAPK, and TP53 was predicted to be involved in the induction of cell death.</p></sec><sec><title>Conclusion</title><p>Through CAGE, we have identified differentially expressed genes that may account for the link between axonal injury and RGC death. Furthermore, an <italic>in silico</italic> pathway analysis provided a global view of alterations in the networks of key regulators of biological pathways that presumably take place in ONC. We thus believe that our study serves as a valuable resource to understand the molecular processes that define axonal injury-driven RGC death.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/1471-2164-15-982) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>CAGE</kwd><kwd>Cap analysis of gene expression</kwd><kwd>Transcription start sites</kwd><kwd>Transcriptome</kwd><kwd>Axonal injury</kwd><kwd>Optic nerve crush</kwd><kwd>Retinal ganglion cells</kwd><kwd>RGC</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Glaucoma, one of the leading causes of blindness worldwide [<xref ref-type="bibr" rid="CR1">1</xref>], is accompanied by unique progressive morphological changes in the optic nerve head, termed &#x0201c;glaucomatous optic neuropathy&#x0201d;. These changes are associated with characteristic patterns of visual field defects [<xref ref-type="bibr" rid="CR2">2</xref>]. The contribution of elevated intraocular pressure (IOP) to glaucoma development and progression is well established, and currently available treatments have focused almost entirely on lowering IOP [<xref ref-type="bibr" rid="CR3">3</xref>]. However, reported data have clearly demonstrated that even a substantial reduction in IOP cannot halt disease progression in many cases, which has led to increased attention to IOP-independent risk factors for glaucoma [<xref ref-type="bibr" rid="CR4">4</xref>]. The understanding that glaucoma is a multifactorial disease has been solidified by strong clinical evidence suggesting that high myopia [<xref ref-type="bibr" rid="CR5">5</xref>], age [<xref ref-type="bibr" rid="CR6">6</xref>], reduced ocular blood flow [<xref ref-type="bibr" rid="CR6">6</xref>], and axonal injury [<xref ref-type="bibr" rid="CR7">7</xref>] may exacerbate glaucoma independently of IOP. Thus, in order to improve the management of glaucoma and mitigate the associated risk of blindness, it is important to improve our understanding of the pathologies that lead to deterioration in vision independently of IOP.</p><p>Axonal injury, possibly related to structural changes in the lamina cribrosa, has been proposed as an IOP-independent factor contributing to glaucoma [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. Histopathological analysis has shown that mechanical stress on the axon bundles at the optic nerve head may occur in patients with glaucoma [<xref ref-type="bibr" rid="CR13">13</xref>]. While such structural changes may be the consequence of age-related degenerative processes [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref>], factors such as ischemia [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], inflammation [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], and oxidative stress [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] may also contribute. Moreover, axonal injury has been suggested to precede visual field defects in glaucoma patients [<xref ref-type="bibr" rid="CR24">24</xref>]. However, little is known about the molecular events that link the injury to the axonal bundles and the death of RGCs (the proximal cause of glaucoma).</p><p>One of the most effective approaches to understand the molecular events that cause RGC death after axonal injury is comprehensive gene expression analysis using animal models. Most past studies that analyzed molecular events after axonal injury to the optic nerve in animal models took a targeted approach, in which one or, at most, a few molecules were selected for characterization [<xref ref-type="bibr" rid="CR25">25</xref>]. Conversely, results obtained through microarray analysis have provided a list of many candidate genes that may be involved in the death of RGCs, providing a global view of change in gene transcription [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. However, microarray analyses rely on the hybridization of a set of known transcripts and are not as comprehensive as sequencing-based techniques [<xref ref-type="bibr" rid="CR28">28</xref>]. In order to overcome this problem, we recently performed RNA sequencing (RNA-seq) using a next-generation sequencer on the eyes of mice which had undergone optic nerve crush (ONC) [<xref ref-type="bibr" rid="CR29">29</xref>]. Profiling gene expression in these eyes uncovered a number of differentially expressed genes (DEGs) that may characterize ongoing biological processes in the ONC. Nevertheless, this technique relies on the comprehensive sequencing of random fragments of RNA with little attention to transcription start sites (TSSs) [<xref ref-type="bibr" rid="CR28">28</xref>]. From this perspective, cap analysis of gene expression (CAGE) can be considered a complementary technique to RNA-seq, as CAGE analysis depends on the construction of full-length cDNA libraries and counting of the short tags at the 5&#x02032; end of the transcripts [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. In this way, the distribution of TSSs and networks of gene transcription can be studied comprehensively and quantitatively on a genome-wide scale. CAGE analysis is more efficient than conventional Rapid Amplification of cDNA End or EST analysis, as high throughput is possible at a relatively low cost [<xref ref-type="bibr" rid="CR32">32</xref>]. The usefulness and power of this technique have been widely recognized through its contribution to the &#x0201c;Encyclopedia of DNA Elements&#x0201d; (ENCODE) project, which elucidated the global distribution of promoter areas in the human genome and the regulatory network of transcription factors [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].</p><p>In this study, we applied CAGE analysis to retinal samples 2&#x000a0;days after ONC, in order to comprehensively study changes in gene transcription at TSSs. Using CAGE data, we attempted to determine dynamic changes in the regulation of the transcriptional network mediating RGC death after axonal injury.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><sec id="Sec3"><title>Animals</title><p>Forty-six C57BL/6 mice (male, 12&#x000a0;weeks old; SLC, Hamamatsu, Japan) were used in this study. The surgical procedures were performed under deep anesthesia, which used intramuscular administration of a mixture of ketamine (100&#x000a0;mg/kg) and xylazine (9&#x000a0;mg/kg). All animals were maintained and handled in accordance with the guidelines of the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the guidelines from the Declaration of Helsinki. All experimental procedures described in the present study were approved by the Ethics Committee for Animal Experiments at Tohoku University Graduate School of Medicine.</p></sec><sec id="Sec4"><title>Induction of axonal injury</title><p>Axonal injury was induced by ONC as previously described [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Briefly, the optic nerve was exposed, and then crushed 2&#x000a0;mm posterior to the globe with fine forceps for 10&#x000a0;seconds. We confirmed that retinal blood circulation was normal with a fundus examination, and then applied antibiotic ointment. We also performed sham operations on a separate group of mice, in which the procedure was similar but the optic nerve was not crushed.</p></sec><sec id="Sec5"><title>RNA preparation</title><p>Total RNA was purified from each retinal sample as previously described [<xref ref-type="bibr" rid="CR29">29</xref>]. Two days after surgery, the retinas were extracted and immediately immersed in RNAlater RNA Stabilization Reagent (Qiagen, Valencia, CA). The retinas were then homogenized in Qiazol (Qiagen) with a pestle homogenizer, and total RNA was extracted from the homogenized mixture with a miRNeasy mini kit (Qiagen). The resulting 46 individual samples (23 in each group) were then assessed with a spectrophotometer to estimate their total RNA concentration (NanoDrop 2000c, Thermo Scientific). To prepare the RNA samples for CAGE, fixed quantities of RNA were taken from six samples and combined into a single sample, in order to minimize the influence of individual variations in the mice [<xref ref-type="bibr" rid="CR29">29</xref>]. The quality of these six combined RNA samples was then assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies). The RNA integrity number of each combined sample used for the cDNA preparation is shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.</p></sec><sec id="Sec6"><title>CAGE library preparation and sequencing</title><p>A CAGE cDNA library was prepared as previously described [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], with minor adaptations for the Illumina sequencer platform [<xref ref-type="bibr" rid="CR38">38</xref>]. Five &#x003bc;g of RNA from each retinal sample were used to synthesize single-strand cDNA. The cDNA was then reverse-transcribed with a random primer N6 primer (5&#x02032;-TCTNNNNNN-3&#x02032;). The resulting cDNA/RNA hybrids were oxidized with NaIO<sub>4</sub> in order to open the diol at the 5&#x02032; end on the cap structure, and the diol group at the 3&#x02032; end of each RNA strand. The derived oxidized dialdehyde of the cap site and 3&#x02032; ends of the RNA strands were biotinylated with biotin (long arm) hydrazide (Vector Laboratories) and treated with RNaseONE (Promega) in order to remove the 3&#x02032; end of each RNA strand and the biotinylated cap when cDNA failed to reach the 5&#x02032; ends. The biotinylated 5&#x02032; end of each RNA strand was selectively trapped with magnetic streptavidin beads (Dynabeads MyOne Streptavidin C1 beads, Life Technologies). The captured cDNA was then released from the beads with RNaseONE treatment, and the single-strand cDNA was purified with Agencourt AMPure XP (Beckman Coulter) according to the manufacturer&#x02019;s instructions. A 5&#x02032; linker with a barcoded sequence was ligated to the 5&#x02032; end of the cDNA. The cDNA was purified with Agencourt AMPure XP, and then a 3&#x02032; linker containing an Illumina adapter sequence was ligated to it. The cDNA was again purified with Agencourt AMPure XP, followed by treatment with Shrimp Alkaline Phosphatase (Affymetrics) and USER (NEB) to restrict the upper strand of the 3&#x02032; linker. Second-strand cDNA was synthesized with a second primer consisting of another Illumina adapter sequence. After Exonuclease I (NEB) treatment, the resulting second-strand cDNA was purified with Agencourt AMPure XP. The cDNA concentration of the final product was determined with a Quant-iT PicoGreen dsDNA Assay Kit (Life Technologies).</p><p>Cluster generation of the cDNA was performed with a cBot fluidics device and the Illumina cBot software. One lane of the flow cell was used for sequencing with four-color DNA Sequencing-By-Synthesis (SBS) technology using the Illumina HiSeq 2000 (Illumina, San Diego, CA). The sequencing run and the base call analysis were performed according to the manufacturer's protocol with a TruSeq SBS kit v3-HS (Illumina). After the sequencing, raw sequence data were generated by Illumina RTA 1.12.4.2 and CASAVA-1.8.2. The sequence data were recorded as FASTQ files. All CAGE sequence data are available under the accession number DRA002410.</p></sec><sec id="Sec7"><title>CAGE data processing and differential expression analysis</title><p>For processing and analysis of sequenced CAGE data, we used an integrated platform provided by the Data Analysis Center of the Cell Innovation Program (<ext-link ext-link-type="uri" xlink:href="http://cell-innovation.nig.ac.jp">http://cell-innovation.nig.ac.jp</ext-link>). The overall workflow is shown in Additional file <xref rid="MOESM2" ref-type="media">2</xref>. Primary data processing of the sequenced data was performed with the nAnT-iCAGE pipeline [<xref ref-type="bibr" rid="CR36">36</xref>]. Read alignment and sequence mapping were performed with BWA software [<xref ref-type="bibr" rid="CR39">39</xref>]. All sequence reads were mapped to the reference genome (NCBI37/mm9). The mapped data were recorded in the SAM format file, and converted to BAM files with SAMtools [<xref ref-type="bibr" rid="CR40">40</xref>]. The mapping quality was assessed with SAMStat software [<xref ref-type="bibr" rid="CR41">41</xref>]. All the processed data in the BAM files were imported to a RECLU pipeline [<xref ref-type="bibr" rid="CR42">42</xref>]. The RECLU is a method of implementing clustering, differential expression analyses, and motif discovery analyses. The core steps of the RECLU pipeline include clustering of individual TSSs with a modified version of the Paraclu algorithm, merging overlapping peaks in different replicates and applying an irreproducible discovery analysis (IDR) to select reproducible peaks [<xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. In order to apply the Paraclu methods to CAGE datasets, the mapped reads were converted into the CAGE-defined transcriptional start sites format. The mapped reads at each site were counted with SAMtools. In the modified Paraclu program, a normalized tag per million (TPM) per base threshold was used and clusters with &#x0003c;&#x02009;0.1 TPM per base were omitted [<xref ref-type="bibr" rid="CR42">42</xref>]. Both the original and modified Paraclu programs define clusters as maximal scoring segments, found by varying a density parameter (d) [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. In this study, the stability of each cluster, defined as max d/min d, was calculated with the modified Paraclu program. If a particular segment had maximal scoring over a large range of values for d, we considered it to be a stable cluster [<xref ref-type="bibr" rid="CR42">42</xref>]. The IDR is a reproducibility criterion analogous to the false discovery rate (FDR) [<xref ref-type="bibr" rid="CR44">44</xref>]. We only selected clusters with an IDR &#x0003c;&#x02009;0.1. Differential gene expression analysis was performed with the Bioconductor package &#x02018;edgeR&#x02019; [<xref ref-type="bibr" rid="CR46">46</xref>]. DEGs were defined as having an FDR adjusted <italic>P</italic>-value &#x0003c;&#x02009;0.05 along with absolute fold-change &#x0003e;&#x02009;1.5. The AMD [<xref ref-type="bibr" rid="CR47">47</xref>], GLAM2 [<xref ref-type="bibr" rid="CR48">48</xref>], Weeder [<xref ref-type="bibr" rid="CR49">49</xref>], and DREME [<xref ref-type="bibr" rid="CR50">50</xref>] programs were used to identify motifs [<xref ref-type="bibr" rid="CR42">42</xref>], and the Tomtom program [<xref ref-type="bibr" rid="CR51">51</xref>] was used to compare standard motif representations in the JASPAR core database [<xref ref-type="bibr" rid="CR52">52</xref>].</p></sec><sec id="Sec8"><title>Quantitative real-time PCR</title><p>Ten samples of purified RNA (n =&#x02009;5 in each group) were used in a quantitative real-time PCR (qRT-PCR) analysis. Total RNA (200&#x000a0;ng per sample) from each sample was reverse-transcribed into cDNA using SuperScript III (Invitrogen Life Technologies, Carlsbad, CA). QRT-PCR was then performed with a 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA) as previously described [<xref ref-type="bibr" rid="CR53">53</xref>]. For each 20&#x000a0;&#x003bc;l reaction the following were used: 10&#x000a0;&#x003bc;l TaqMan Fast Universal PCR Master Mix (Applied Biosystems, Foster City, CA), 1&#x000a0;&#x003bc;l Taqman probe, 1&#x000a0;&#x003bc;l template DNA, and 8&#x000a0;&#x003bc;l DEPC water. For a relative comparison of gene expression, we analyzed the results of the qRT-PCR data with the comparative Ct method (2<sup>- &#x02206;&#x02206;CT</sup>), normalized to <italic>Gapdh</italic>, an endogenous control. All Taqman probes used for these reactions are listed in Additional file <xref rid="MOESM3" ref-type="media">3</xref>.</p></sec><sec id="Sec9"><title>Pathway analysis</title><p><italic>In silico</italic> pathway analyses were performed with Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Redwood City, CA) as previously described [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. The DEG datasets were uploaded to the IPA application and mapped to the Ingenuity Pathways Knowledge Base (IPKB). Each gene identifier was then mapped to its corresponding IPKB. Duplication of genes in the DEG datasets was resolved by selecting the gene with the maximum fold-change value [<xref ref-type="bibr" rid="CR56">56</xref>]. Networks of these genes were generated based on their connectivity. The significance of the association between the datasets and biofunctions was measured as the ratio of the number of genes from the dataset that mapped to the pathway divided by the total number of genes in that pathway. An upstream regulator analysis was performed to compare DEGs in the datasets to those known to be regulated by a given upstream regulator. Based on the concordance between them, an activation score was assigned, showing whether a potential transcriptional regulator was in an &#x0201c;activated&#x0201d; (z-score&#x02009;&#x02265;&#x02009;2), &#x0201c;inhibited&#x0201d; (z-score&#x02009;&#x02264;&#x02009;-2), or uncertain state. The regulator effects analysis was also performed with IPA, in order to discover relationships between upstream regulators and downstream functions and diseases. Only regulators and downstream functions and diseases with <italic>P</italic> &#x0003c;&#x02009;0.05 and |z- score|&#x02009;&#x02265;&#x02009;2 were used in this analysis. The regulator effects algorithm connects upstream regulators, dataset molecules and downstream functions or diseases affected in the dataset to generate a hypothesis that can explain how the upstream regulators affect the downstream target molecule expression and the impact of the molecular expression on functions and diseases. The consistency score, a measure of the causal consistency and density of connection in a regulator effects network, was also calculated with IPA.</p></sec><sec id="Sec10"><title>Statistical analysis</title><p>Differential gene expression analysis of CAGE data was performed with the R Bioconductor package &#x02018;edgeR&#x02019; integrated in the RECLU pipeline, as described above. <italic>P</italic>-values were adjusted for multiplicity with Benjamini-Hochberg correction with edgeR. Genes with adjusted <italic>P</italic>-values &#x0003c;&#x02009;0.05 and absolute fold-change &#x0003e;&#x02009;1.5 were considered DEGs in the CAGE analysis.</p><p>QRT-PCR data were analyzed with the Welch&#x02019;s <italic>t</italic>-test. Statistical analysis of the qRT-PCR data was performed with R software (version 3.1.0) [<xref ref-type="bibr" rid="CR57">57</xref>]. The significance of the pathway analysis was calculated with Fisher&#x02019;s exact test in the IPA application. If the <italic>P</italic>-values for qRT-PCR and IPA were less than 0.05, the results were considered statistically significant.</p></sec></sec><sec id="Sec11" sec-type="results"><title>Results</title><sec id="Sec12"><title>Validation of the CAGE data</title><p>Previously, we obtained experimental data indicating that RGC death starts approximately 3&#x000a0;days after ONC in mice [<xref ref-type="bibr" rid="CR25">25</xref>]. As our primary interest was to use the CAGE data to search for therapeutic targets for RGC preservation, we examined changes in the retina on 2&#x000a0;days after ONC (Day 2), in order to observe the molecular events preceding the actual death of the cells. Total RNA was extracted from 3 independent retinal samples, each of which was derived from 6 retinas extracted from 6 different mice. CAGE was then performed on these 3 samples. The analysis workflow for the data derived from CAGE is well established [<xref ref-type="bibr" rid="CR42">42</xref>]. An outline of the process is shown in Additional file <xref rid="MOESM2" ref-type="media">2</xref>.</p><p>Before beginning the analysis of the CAGE data, we evaluated its integrity (Additional file <xref rid="MOESM1" ref-type="media">1</xref>). We found that, in all samples, at least 89.8% of the sequence data mapped to the reference genome (NCBI37/mm9), assuring that the overall quality of the CAGE data was high. Furthermore, the MAPQ value, which represents the mapping quality of each sample, was more than 30 in at least 75.3% of the mapped data. Finally, we tested the gross consistency of the data among biological samples by comparing pairs of expression data derived from each treatment group using the modified Paraclu and the IDR program in the RECLU pipeline. The IDR analysis was used to quantitatively measure consistency between biological replicates and to select reproducible signals. These analyses revealed that the expression patterns in sets of data derived from independent samples taken from the same group were highly similar (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>), assuring the high integrity of the CAGE datasets. Taken together, the quality of the data thus met the reliability requirements for downstream processing [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR58">58</xref>].<fig id="Fig1"><label>Figure 1</label><caption><p><bold>Stability and reproducibility of the biological replicates used for CAGE.</bold> The scatter plots show the correlation between expression values in replicates 1 and 2 in both the sham <bold>(A)</bold> and ONC <bold>(C)</bold> groups. Stability is a score used for clustering reproducible TSSs in multiple replicates. Green dots indicate high reproducibility and red dots indicate low reproducibility. The bar graphs represent a reproducibility evaluation for each pair of replicates in the sham <bold>(B)</bold> and ONC <bold>(D)</bold> groups. Green indicates TSS clusters with high reproducibility between the replicates. Red indicates TSS clusters with low reproducibility between the replicates.</p></caption><graphic xlink:href="12864_2014_6671_Fig1_HTML" id="d30e665"/></fig></p></sec><sec id="Sec13"><title>Comparative analysis of DEGs</title><p>After assessing the quality of the CAGE data and defining the TSSs of our data, we used the edgeR package to perform a differential expression analysis of the transcripts at each TSS in the eyes subjected to ONC and the eyes that received a sham procedure. Consequently, we identified 400 differentially expressed TSSs, which included 180 annotated (Additional file <xref rid="MOESM4" ref-type="media">4</xref>) and 220 unannotated TSS clusters (Additional file <xref rid="MOESM5" ref-type="media">5</xref>). We further divided the 180 annotated DEGs into 6 groups of genes based on their retinal cell type, i.e., RGCs, microglia, photoreceptors, amacrine cells, horizontal cells, and bipolar cells, using published microarray gene expression data [<xref ref-type="bibr" rid="CR59">59</xref>]. According to the microarray database, 55 of 180 DEGs were expressed more specifically in one of the first 5 of these retinal cell types (Additional file <xref rid="MOESM6" ref-type="media">6</xref>). However, no DEGs specific to bipolar cells were detected in this study. We found that 88.9% of the genes that were relatively specific to RGCs were down-regulated in the ONC retinas, which was in sharp contrast with other cell types studied (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). This pattern of expression is, in fact, in good agreement with the expected reduction of transcription in severely injured RGCs [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>], further validating the biological accuracy of the CAGE data.<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Overall reduction in the RGC-specific transcriptome.</bold> The horizontal histogram shows the number of DEGs in each retinal cell type [<xref ref-type="bibr" rid="CR59">59</xref>]. Red: up-regulated, Blue: down-regulated. *No DEGs specific to bipolar cells were detected in this study.</p></caption><graphic xlink:href="12864_2014_6671_Fig2_HTML" id="d30e707"/></fig></p><p>Next, we determined if there were specific correlations between the level of transcripts at a given TSS and the level of transcripts detectable by qRT-PCR. The expression of six randomly selected highly significant DEGs (<italic>Bcat1</italic>, <italic>Cox6a2</italic>, <italic>Crabp2</italic>, <italic>Fxyd7</italic>, <italic>Gng4</italic> and <italic>Tppp3</italic>) was quantified by choosing the primer pair downstream of the TSS of interest. Conventional qRT-PCR showed a significant difference in expression in the six genes in the sham-treated and ONC samples (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). This was consistent with the differential expression patterns observed in the CAGE data.<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Validation of selected DEGs with qRT-PCR.</bold> Transcriptional changes in six selected DEGs were validated with qRT-PCR <bold>(A-F)</bold>. The graphs show the level of mRNA expression in the ONC group relative to the sham group. The average expression for sham group was normalized as a 1.0-fold change. Values are mean&#x02009;&#x000b1;&#x02009;SD (n =&#x02009;5 in each group, **<italic>P</italic> &#x0003c;&#x02009;0.01).</p></caption><graphic xlink:href="12864_2014_6671_Fig3_HTML" id="d30e749"/></fig></p><p>The type of TSS could also be further classified based on the distribution of the mapped tags forming two different types of clusters with sharp TATA-box-associated promoters (top peaks) and broad CpG-associated promoters (bottom peaks) ([<xref ref-type="bibr" rid="CR62">62</xref>]) (Additional file <xref rid="MOESM7" ref-type="media">7</xref>). The 10 most significantly up- or down-regulated DEGs at the top and bottom peaks are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. We found that 45% of the top 10 up-regulated DEGs and 55% of the top 10 down-regulated DEGs at either or both peaks after ONC were also up-regulated in the RNAseq data derived from the same model [<xref ref-type="bibr" rid="CR29">29</xref>]. Meanwhile, 75% of the up-regulated DEGs and 45% of the down-regulated DEGs were also identified as DEGs in the microarray data derived from mouse retinas 3&#x000a0;days after ONC, one day later than the current study [<xref ref-type="bibr" rid="CR27">27</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Top 10 up- and down-regulated genes in each peak type after ONC</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>Gene accession</th><th>Log
<sub>2</sub> fold-change</th><th>Adjusted <italic>P</italic>-value</th></tr></thead><tbody><tr><td colspan="4">
<bold>Up-regulated at top peaks</bold>
</td></tr><tr><td>
<italic>Bcat1</italic>
</td><td>NM_007532</td><td>6.70</td><td>7.80E-04</td></tr><tr><td>
<italic>Sprr1a</italic>
</td><td>NM_009264</td><td>4.66</td><td>1.80E-23</td></tr><tr><td>
<italic>Mmp12</italic>
</td><td>NM_008605</td><td>4.36</td><td>1.70E-39</td></tr><tr><td>
<italic>Adcyap1</italic>
</td><td>NM_009625</td><td>4.27</td><td>7.10E-08</td></tr><tr><td>
<italic>Zfp275</italic>
</td><td>NM_001160229</td><td>3.88</td><td>3.50E-02</td></tr><tr><td>
<italic>Ecel1</italic>
</td><td>NM_001277925</td><td>3.60</td><td>2.00E-07</td></tr><tr><td>
<italic>Crabp2</italic>
</td><td>NM_007759</td><td>3.56</td><td>2.60E-10</td></tr><tr><td>
<italic>Arhgef2</italic>
</td><td>NM_001198911</td><td>3.53</td><td>2.40E-02</td></tr><tr><td>
<italic>Gal</italic>
</td><td>NM_010253</td><td>3.49</td><td>7.60E-07</td></tr><tr><td>
<italic>Asns</italic>
</td><td>NM_012055</td><td>3.44</td><td>3.50E-06</td></tr><tr><td colspan="4">
<bold>Up-regulated at bottom peaks</bold>
</td></tr><tr><td>
<italic>Sprr1a</italic>
</td><td>NM_009264</td><td>4.76</td><td>3.90E-31</td></tr><tr><td>
<italic>Mmp12</italic>
</td><td>NM_008605</td><td>4.14</td><td>1.80E-51</td></tr><tr><td>
<italic>Ecel1</italic>
</td><td>NM_001277925</td><td>3.74</td><td>1.60E-20</td></tr><tr><td>
<italic>Crabp2</italic>
</td><td>NM_007759</td><td>3.55</td><td>2.40E-11</td></tr><tr><td>
<italic>Gal</italic>
</td><td>NM_010253</td><td>3.49</td><td>1.80E-18</td></tr><tr><td>
<italic>Cox6a2</italic>
</td><td>NM_009943</td><td>3.25</td><td>2.50E-11</td></tr><tr><td>
<italic>Thoc7</italic>
</td><td>NM_001013578</td><td>3.21</td><td>9.10E-03</td></tr><tr><td>
<italic>Zfand2b</italic>
</td><td>NM_026846</td><td>3.20</td><td>2.00E-04</td></tr><tr><td>
<italic>Tnfrsf12a</italic>
</td><td>NM_001161746</td><td>2.95</td><td>6.60E-06</td></tr><tr><td>
<italic>Arhgef2</italic>
</td><td>NM_001198911</td><td>2.92</td><td>3.00E-09</td></tr><tr><td colspan="4">
<bold>Down-regulated at top peaks</bold>
</td></tr><tr><td>
<italic>Gng4</italic>
</td><td>NM_010317</td><td>-6.39</td><td>7.50E-03</td></tr><tr><td>
<italic>Ak4</italic>
</td><td>NM_009647</td><td>-3.45</td><td>2.50E-02</td></tr><tr><td>
<italic>Ndufa13</italic>
</td><td>NM_023312</td><td>-3.02</td><td>3.10E-02</td></tr><tr><td>
<italic>Tusc5</italic>
</td><td>NM_177709</td><td>-2.40</td><td>1.70E-04</td></tr><tr><td>
<italic>Nrgn</italic>
</td><td>NM_022029</td><td>-2.20</td><td>8.00E-03</td></tr><tr><td>
<italic>Fxyd7</italic>
</td><td>NM_022007</td><td>-2.15</td><td>7.50E-12</td></tr><tr><td>
<italic>Ctxn3</italic>
</td><td>NM_001134697</td><td>-2.09</td><td>4.60E-03</td></tr><tr><td>
<italic>Tppp3</italic>
</td><td>NM_026481</td><td>-1.58</td><td>3.00E-02</td></tr><tr><td>
<italic>Pvalb</italic>
</td><td>NM_013645</td><td>-1.53</td><td>1.80E-05</td></tr><tr><td>
<italic>Sncg</italic>
</td><td>NM_011430</td><td>-1.46</td><td>4.60E-03</td></tr><tr><td colspan="4">
<bold>Down-regulated at bottom peaks</bold>
</td></tr><tr><td>
<italic>Scarna9</italic>
</td><td>NR_028568</td><td>-2.66</td><td>3.10E-02</td></tr><tr><td>
<italic>Tusc5</italic>
</td><td>NM_177709</td><td>-2.43</td><td>9.10E-06</td></tr><tr><td>
<italic>Cnn3</italic>
</td><td>NM_028044</td><td>-2.41</td><td>8.60E-03</td></tr><tr><td>
<italic>Fxyd7</italic>
</td><td>NM_022007</td><td>-1.62</td><td>4.50E-13</td></tr><tr><td>
<italic>Ctxn3</italic>
</td><td>NM_001134697</td><td>-1.58</td><td>1.80E-04</td></tr><tr><td>
<italic>Rasgrp2</italic>
</td><td>NM_011242</td><td>-1.47</td><td>2.20E-07</td></tr><tr><td>
<italic>Tmsb10</italic>
</td><td>NM_001039392</td><td>-1.44</td><td>4.50E-05</td></tr><tr><td>
<italic>Bcl2</italic>
</td><td>NM_009741</td><td>-1.43</td><td>6.80E-03</td></tr><tr><td>
<italic>1500009C09Rik</italic>
</td><td>NR_037698</td><td>-1.41</td><td>4.30E-05</td></tr><tr><td>
<italic>Oasl1</italic>
</td><td>NM_145209</td><td>-1.34</td><td>4.30E-05</td></tr></tbody></table><table-wrap-foot><p>Differences were considered significant with an adjusted <italic>P</italic>-value &#x0003c;&#x02009;0.05 and |fold-change| &#x0003e;&#x02009;1.5.</p></table-wrap-foot></table-wrap></p><p>In some DEGs, we found evidence of the emergence of alternative promoters after ONC. For example, in the sham-treated eyes, transcription of <italic>Tnfrsf12a</italic> was almost exclusively dependent on the TSS of exon 1 of the reference transcript (NM_013749). However, in the retinal samples from the ONC eyes, a cryptic promoter embedded around exon 2 emerged as an equally dominant TSS (Additional file <xref rid="MOESM8" ref-type="media">8</xref>). We also performed a promoter database search with ZENBU [<xref ref-type="bibr" rid="CR63">63</xref>], which contains FANTOM5 (Functional Annotation of Mammalian Genome 5) datasets [<xref ref-type="bibr" rid="CR64">64</xref>]. According to ZENBU, the use of this <italic>Tnfrsf12a</italic> promoter has been already recognized in hepatocyte and Schwann cells.</p><p>Furthermore, we discovered that 34 of the 220 unannotated TSS clusters differentially expressed 2&#x000a0;days after ONC did not have any CAGE peaks in ZENBU (Additional file <xref rid="MOESM5" ref-type="media">5</xref>). These 34 TSS clusters may therefore include novel promoters and/or novel long non-coding RNAs specifically affected by axonal injury. We investigated the tissue specificity of the remaining 186 unannotated TSSs registered in ZENBU. However the database did not contain specific expression profile data for the retina, but only for the whole eye. According to ZENBU, 6 of the 186 unannotated TSSs were specifically expressed in the murine eye (Additional file <xref rid="MOESM5" ref-type="media">5</xref>).</p></sec><sec id="Sec14"><title><italic>In silico</italic>pathway analysis of the DEGs</title><p>An <italic>in silico</italic> pathway analysis of the bioinformatics of the 180 DEGs revealed five potential biological processes that occurred differentially in the retinas of the ONC and sham-treated groups. Among these processes, 42 DEGs contributing to the &#x0201c;Cell Death and Survival&#x0201d; pathway emerged as the most significant (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Since one of our main goals was to understand the molecular network that mediates the death of RGCs in axonal injury, we took a deeper look into the DEGs that contributed to this pathway (Additional file <xref rid="MOESM9" ref-type="media">9</xref>). Based on the information in Additional files <xref rid="MOESM4" ref-type="media">4</xref> and <xref rid="MOESM9" ref-type="media">9</xref>, we generated a file that lists the DEGs in the &#x0201c;Cell Death and Survival&#x0201d; pathways, and indicates their involvement in the &#x0201c;Cell death&#x0201d; and &#x0201c;Cell survival&#x0201d; pathways, as well as their gene expression changes 2&#x000a0;days after ONC (Additional file <xref rid="MOESM10" ref-type="media">10</xref>). We found that the endoplasmic reticulum (ER) stress-related genes <italic>Atf3</italic>, <italic>Ddit3</italic>, <italic>Egr1</italic> and <italic>Jun</italic> [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>], which belong to the cell death pathway, were up-regulated 2&#x000a0;days after ONC (Additional file <xref rid="MOESM10" ref-type="media">10</xref>). <italic>Bbc3</italic>, a pro-apoptotic BH3-only gene [<xref ref-type="bibr" rid="CR67">67</xref>] was also up-regulated (Additional file <xref rid="MOESM4" ref-type="media">4</xref>). Additionally, <italic>Bcl2</italic> [<xref ref-type="bibr" rid="CR68">68</xref>], <italic>Park7</italic> [<xref ref-type="bibr" rid="CR69">69</xref>] and <italic>Serpinf1</italic> [<xref ref-type="bibr" rid="CR70">70</xref>], which belong to the cell survival pathway, had altered expression 2&#x000a0;days after ONC: <italic>Bcl2</italic> was down-regulated, whereas <italic>Park7</italic> and <italic>Serpinf1</italic> were up-regulated (Additional file <xref rid="MOESM10" ref-type="media">10</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>Top 5 molecular and cellular biological pathways significantly altered after ONC</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Category</th><th>
<italic>P</italic>-value</th><th>Number of molecules</th></tr></thead><tbody><tr><td>Cell death and survival</td><td>1.99E-09 - 7.11E-03</td><td>42</td></tr><tr><td>Cellular development</td><td>1.51E-05 - 7.11E-03</td><td>24</td></tr><tr><td>Cellular growth and proliferation</td><td>1.51E-05 - 7.11E-03</td><td>32</td></tr><tr><td>Cell-to-cell signaling and interaction</td><td>2.11E-05 - 7.11E-03</td><td>30</td></tr><tr><td>Cellular function and maintenance</td><td>2.18E-05 - 7.11E-03</td><td>32</td></tr></tbody></table><table-wrap-foot><p>Significances were calculated with Fisher&#x02019;s exact test.</p><p>Differences were considered significant at the <italic>P</italic> &#x0003c;&#x02009;0.05 level.</p></table-wrap-foot></table-wrap></p><p>For the purpose of selecting therapeutic targets, it is useful to understand the hierarchy of a defined molecular network. Therefore, we performed an additional <italic>in silico</italic> analysis to identify the key upstream regulators that govern these networks [<xref ref-type="bibr" rid="CR71">71</xref>]. This analysis revealed six important upstream regulators, each predicted to act upon different sets of target molecules, likely mediating different biological effects (Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>, Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). Additionally, the regulator effects analysis predicted that a regulatory network comprising IFNG, P38 MAPK, and TP53 was involved in cellular death (Additional file <xref rid="MOESM11" ref-type="media">11</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>Predicted protein interaction networks involved in axonal injury.</bold> Prediction of upstream regulators was performed using IPA. The predicted upstream regulators (white nodes) were ATF4, IFNG, TP53, P38MAPK, ALDH2, and ACOX1. The targets of these upstream regulators are also displayed to illustrate the alteration in the interaction networks after ONC. Solid lines represent a direct interaction between two genes, whereas dotted lines represent an indirect relationship. The length of a line reflects the strength of reported evidence supporting the node-to-node relationship. The shapes of the nodes represent the different known biological roles of each of these molecules, as shown in the lower right inset. Red indicates up-regulated genes, green indicates down-regulated genes, and white indicates genes that were not annotated in these CAGE results, but that formed part of the network. *:targets that were duplicated in the dataset.</p></caption><graphic xlink:href="12864_2014_6671_Fig4_HTML" id="d30e1711"/></fig></p><table-wrap id="Tab3"><label>Table 3</label><caption><p>
<bold>Predicted upstream regulators after ONC</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Name</th><th>Predicted change</th><th>Activation z-score</th><th>
<italic>P</italic>-value of overlap</th><th>Target molecules in dataset</th></tr></thead><tbody><tr><td>ATF4</td><td>Activated</td><td>3.14</td><td>6.10E-18</td><td>AARS, ASNS, ATF3, ATF5, BCAT1, CDKN1A, CEBPB, DDIT3, GARS, HERPUD1, MTHFD2, PSAT1, SARS, SERPINF1, TNFRSF12A</td></tr><tr><td>IFNG</td><td>Activated</td><td>2.64</td><td>2.05E-04</td><td>BCL2, CDKN1A, CEBPB, CLIC4, CREM, DDIT3, FCGR2B, GNAO1, MMP12, SPRR1A, TAC1</td></tr><tr><td>P38 MAPK</td><td>Activated</td><td>2.22</td><td>2.42E-06</td><td>BBC3, CDKN1A, EGR1, HMOX1, JUN, NEDD4</td></tr><tr><td>TP53</td><td>Activated</td><td>2.14</td><td>6.99E-05</td><td>APBB2, ATF3, BBC3, BCL2, CDKN1A, CLIC4, CNN3, COL3A1, CSTB, HIST1H1B, HMOX1, HSP90AA1, KITLG, PARK7</td></tr><tr><td>ALDH2</td><td>Inhibited</td><td>-2.22</td><td>1.94E-07</td><td>ATF5, MTHFD2, PHGDH, PSAT1, SLC1A4</td></tr><tr><td>ACOX1</td><td>Inhibited</td><td>-2.00</td><td>1.33E-02</td><td>CDKN1A, CSTB, DDIT3, SQSTM1</td></tr></tbody></table><table-wrap-foot><p>Data were analyzed with Fisher&#x02019;s exact test. Differences were considered significant with a <italic>P</italic>-value &#x0003c;&#x02009;0.05 and |z-score|&#x02009;&#x02265;&#x02009;2. The activation z-score was used to infer the likely activation states of upstream regulators based on a comparison with a model that assigns random regulation directions. The <italic>P</italic>-value overlap, which indicates likely upstream regulators, represents the significance of the overlap between the dataset genes identified here and known targets of transcriptional regulators.</p></table-wrap-foot></table-wrap><p>An alternative way to search for key upstream transcription factors defining the pathology of ONC eyes is to explore the dominant binding motifs embedded near the TSS. For this purpose, we took advantage of a previously established program [<xref ref-type="bibr" rid="CR51">51</xref>] to predict the motifs to which the transcription factor bound. Target motifs were recovered for each of the four patterns of quantitative change in transcription (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> and Additional file <xref rid="MOESM12" ref-type="media">12</xref>). This information predicted that 5 transcription factors (SP1, PAX4, RREB1, Tal1/Gata1 complex and NFATC2) interacted with the recovered motifs and exerted biological effects contributory to the process of axonal injury.<table-wrap id="Tab4"><label>Table 4</label><caption><p>
<bold>List of predicted motif sequences associated with axonal injury</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Motif no.</th><th>Consensus</th><th>Foreground</th><th>Background</th><th>
<italic>P</italic>-value</th><th>Known motifs (<italic>P</italic>-value)</th></tr></thead><tbody><tr><td colspan="6">
<bold>Up-regulated at top peaks</bold>
</td></tr><tr><td>AMD_001</td><td>YNRNAGGTGT</td><td>21</td><td>101</td><td>2.50E-06</td><td>NA</td></tr><tr><td>AMD_002</td><td>CCTNDGNNNGAG</td><td>24</td><td>167</td><td>7.79E-05</td><td>NA</td></tr><tr><td>AMD_003</td><td>WGAGNNTTACCNS</td><td>20</td><td>91</td><td>2.65E-06</td><td>NA</td></tr><tr><td>AMD_005</td><td>GNNNGTGNTGATGNC</td><td>19</td><td>92</td><td>1.30E-05</td><td>NA</td></tr><tr><td>AMD_006</td><td>YDNWNATTCHTAGGYNA</td><td>16</td><td>102</td><td>1.61E-03</td><td>NA</td></tr><tr><td>AMD_007</td><td>CNNNMAGARTNNTTGNMNW</td><td>22</td><td>115</td><td>3.75E-06</td><td>NA</td></tr><tr><td>AMD_009</td><td>ACGNNATAYWNNNA</td><td>16</td><td>92</td><td>5.85E-04</td><td>NA</td></tr><tr><td>GLAM2_001</td><td>SCBCCCBCCCCYCCCCCNCCCB</td><td>34</td><td>330</td><td>2.24E-05</td><td>SP1 (5.25E-08), Pax4 (6.97E-07), RREB1 (5.84E-06)</td></tr><tr><td colspan="6">
<bold>Up-regulated at bottom peaks</bold>
</td></tr><tr><td>AMD_003</td><td>CTGSNYNNAGA</td><td>22</td><td>128</td><td>4.80E-06</td><td>NA</td></tr><tr><td>AMD_004</td><td>SNYAGGWGTCATK</td><td>18</td><td>87</td><td>9.50E-06</td><td>NA</td></tr><tr><td>AMD_006</td><td>ATCNNNNNNBCCAM</td><td>20</td><td>106</td><td>6.28E-06</td><td>Tal1::Gata1 (3.02E-06)</td></tr><tr><td>AMD_009</td><td>CTGNNNNNNNNNTNNANAKANNNA</td><td>21</td><td>162</td><td>5.58E-04</td><td>NA</td></tr><tr><td>GLAM2_004</td><td>CCBCCYCCTCCHBHCHCCC</td><td>33</td><td>371</td><td>1.07E-04</td><td>Pax4 (1.56E-05), SP1 (2.93E-05)</td></tr><tr><td colspan="6">
<bold>Down-regulated at top peaks</bold>
</td></tr><tr><td>AMD_002</td><td>WTCAATGAKWTACANTGWWMW</td><td>20</td><td>193</td><td>5.23E-03</td><td>NA</td></tr><tr><td>AMD_003</td><td>SANKWAMAMTGARAAAMAYM</td><td>23</td><td>237</td><td>3.82E-03</td><td>NA</td></tr><tr><td>GLAM2_005</td><td>TTCTTTYTTBTTYBTYTYYHTTTYT</td><td>30</td><td>360</td><td>8.54E-04</td><td>NA</td></tr><tr><td colspan="6">
<bold>Down-regulated at bottom peaks</bold>
</td></tr><tr><td>GLAM2_006</td><td>AAAMATGRAAAATRANAAAAANCAMA</td><td>24</td><td>327</td><td>0</td><td>NFATC2 (6.39E-05)</td></tr><tr><td>DREME_001</td><td>ACTCATCTA</td><td>13</td><td>56</td><td>2.14E-06</td><td>NA</td></tr><tr><td>DREME_002</td><td>AAAACCACACTGTA</td><td>18</td><td>124</td><td>1.42E-06</td><td>NA</td></tr><tr><td>DREME_003</td><td>ATGAGTTAC</td><td>12</td><td>38</td><td>5.11E-07</td><td>NA</td></tr><tr><td>DREME_004</td><td>AGTTACACTGAA</td><td>14</td><td>83</td><td>1.65E-05</td><td>NA</td></tr><tr><td>DREME_006</td><td>TACACTGTTCTACA</td><td>12</td><td>87</td><td>5.72E-04</td><td>NA</td></tr><tr><td>DREME_007</td><td>ATTCGTTGG</td><td>8</td><td>22</td><td>3.70E-05</td><td>NA</td></tr><tr><td>DREME_008</td><td>ATATTTCA</td><td>16</td><td>99</td><td>3.37E-06</td><td>NA</td></tr><tr><td>DREME_009</td><td>AATGAGAAAC</td><td>14</td><td>74</td><td>5.10E-06</td><td>NA</td></tr><tr><td>DREME_010</td><td>TCACTAAAA</td><td>14</td><td>104</td><td>1.62E-04</td><td>NA</td></tr><tr><td>DREME_011</td><td>ACTGTAGGA</td><td>15</td><td>82</td><td>2.43E-06</td><td>NA</td></tr><tr><td>DREME_012</td><td>AAACGGGATT</td><td>10</td><td>73</td><td>2.26E-03</td><td>NA</td></tr><tr><td>DREME_013</td><td>HTATGAA</td><td>15</td><td>78</td><td>1.40E-06</td><td>NA</td></tr><tr><td>DREME_014</td><td>ATATGTTC</td><td>16</td><td>102</td><td>4.82E-06</td><td>NA</td></tr></tbody></table><table-wrap-foot><p>Foreground values indicate the number of occurrences of a motif sequence in DEGs after ONC.</p><p>Background values indicate the number of occurrences of a motif sequence in non-DEGs after ONC.</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec15" sec-type="discussion"><title>Discussion</title><p>In this study, CAGE analysis was performed on retinal RNA samples collected 2&#x000a0;days after the ONC procedure, to comprehensively and quantitatively compare TSSs scattered throughout the genome and elucidate the molecular pathomechanisms underlying the RGC death induced by axonal injury. Through the use of a unique analysis pipeline, our study identified a list of DEGs with high value.</p><p>On a global level, we observed that transcription of DEGs in the RGCs was generally depressed. This pattern of expression change was unique to DEGs in the RGCs, as DEGs in the other cell types (microglia, photoreceptors, and amacrine cells) showed the opposite trend. In fact, we were rather surprised to see up-regulation of genes specific to photoreceptors and amacrine cells. We suspect that inflammatory soluble factor production may have exerted an off-target stimulatory effect, as a paradoxical increase in retinal function has been reported in the early phases of intraocular inflammation [<xref ref-type="bibr" rid="CR72">72</xref>]. Meanwhile, it was not surprising to observe the up-regulation of all 14 DEGs specifically expressed in microglia, as these cells have an important role in scavenging dying neurons [<xref ref-type="bibr" rid="CR73">73</xref>]. One of these 14 DEGs, <italic>Clic1,</italic> is involved in the production of reactive oxygen species [<xref ref-type="bibr" rid="CR74">74</xref>], which could be a key mediator of RGC death, as oxidative stress is known to contribute to the pathology of axonal injury [<xref ref-type="bibr" rid="CR75">75</xref>]. In this study, we only examined changes in gene expression 2&#x000a0;days after ONC because, unlike the sham group, the number of RGCs significantly decreases at later time points in ONC group, which can complicate the direct comparison of gene expression between the two groups. However, it has been reported that inflammation and oxidative stress, as well as ER stress, are more activated at later time points after axonal injury [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. Therefore, it is also important to evaluate changes in transcriptome profiles in these later stages, and we hope to investigate them in a future study using a different approach.</p><p>Among the 180 DEGs, <italic>Bcat1</italic> showed the largest expression difference (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The validity of this CAGE data was verified with conventional qRT-PCR, which showed that expression increased in the ONC eyes by ~16.1-fold (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). This gene is therefore highly interesting as a therapeutic target, but its involvement in axonal injury and RGC death has not yet been reported. <italic>Bcat1</italic> encodes the enzyme branched-chain amino acid transaminase and is the target of c-Myc. It can reportedly induce cell death by causing the production of excessive branched-chain keto acids through transamination [<xref ref-type="bibr" rid="CR77">77</xref>]. It is also possible that this gene mediates the death of the RGCs via a similar mechanism.</p><p>Our <italic>in silico</italic> pathway analysis revealed that the &#x0201c;Cell Death and Survival&#x0201d; pathway was the most significant biological process in the ONC retinas (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Among relevant DEGs, genes involved in ER stress eventually leading to cell death, such as <italic>Atf3</italic> and <italic>Ddit3,</italic> were up-regulated 2&#x000a0;days after ONC (Additional files <xref rid="MOESM4" ref-type="media">4</xref> and <xref rid="MOESM10" ref-type="media">10</xref>). It has been reported that <italic>Ddit3</italic> up-regulates mRNA expression of <italic>Bbc3</italic>, a cell death-related gene [<xref ref-type="bibr" rid="CR78">78</xref>], and also down-regulates mRNA expression of <italic>Bcl2</italic>, a cell survival-related gene [<xref ref-type="bibr" rid="CR79">79</xref>]. Up-regulation of <italic>Bbc3</italic> and down-regulation of <italic>Bcl2</italic> were confirmed in this study (Additional file <xref rid="MOESM4" ref-type="media">4</xref>) and may be caused by the increased transcription of <italic>Ddit</italic>3 and activation of ER stress as a mechanism of RGC death after ONC.</p><p>We also found that <italic>Serpinf1</italic> (aka <italic>Pedf</italic>) was a cell survival-related DEG (Additional file <xref rid="MOESM10" ref-type="media">10</xref>). <italic>Serpinf1</italic> reportedly plays a neuroprotective role in ONC [<xref ref-type="bibr" rid="CR80">80</xref>]. <italic>Park7</italic> was also classified as a cell survival-related DEG (Additional file <xref rid="MOESM10" ref-type="media">10</xref>). Previous reports showed that the translated protein of <italic>Park7</italic> increased 4&#x000a0;days after ONC in rats [<xref ref-type="bibr" rid="CR81">81</xref>] and that mutations in <italic>Park7</italic> were associated with Parkinson&#x02019;s disease (PD) [<xref ref-type="bibr" rid="CR82">82</xref>]. Animal models of PD have suggested that the translated protein exerts an anti-oxidative effect that leads to neuroprotection [<xref ref-type="bibr" rid="CR83">83</xref>]. While the role of <italic>Park7</italic> in the pathology of ONC is still unclear, it is possible that a similar anti-oxidative mechanism may protect the RGCs from axonal injury-induced death.</p><p>The significance of our findings was reinforced by the <italic>in silico</italic> identification of networks of DEGs and the prediction of the most significant upstream regulators for each network, including the prediction that ATF4 was an up-stream regulator of the ER stress pathway (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). It is conceivable that ATF4 could increase the transcription of ER stress-related genes, including <italic>Aft3</italic> and <italic>Ddit3</italic>, which may ultimately promote RGC death [<xref ref-type="bibr" rid="CR84">84</xref>]. We found similar up-regulation of ER stress-related genes in RNA-seq data obtained with a similar experimental design comparing ONC and sham-treated eyes [<xref ref-type="bibr" rid="CR84">84</xref>]. Interestingly, <italic>Bcat1</italic> was also included as a target of ATF4. The list of predicted upstream regulators of altered pathways also included P38MAPK and TP53, both implicated in RGC death after ONC [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>].</p><p>In addition, we performed a motif discovery analysis and determined that the SP1 (Sp1 transcription factor) motif was differentially up-regulated at bottom peaks (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). SP1 is a zinc-finger transcription factor that binds to GC-rich elements [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. It has been reported to regulate the transcription of damage-induced neuronal endopeptidase (DINE) through interaction with ATF3, c-Jun, and STAT3 [<xref ref-type="bibr" rid="CR89">89</xref>]. DINE is also known as <italic>Ecel1</italic> [<xref ref-type="bibr" rid="CR90">90</xref>], which was up-regulated after ONC in this study. Therefore, SP1 may be implicated in transcription regulation after axonal injury.</p><p>Despite CAGE and RNA-seq using clearly different quantitative methods to evaluate gene expression, we found that they had a certain degree of commonality in their final output when identifying DEGs. However, CAGE did provide us with a unique insight into differences in TSSs, especially through its analysis of the differential use of multiple promoters within a given gene, and through the discovery of the associated DNA-binding motifs. However, at this point, we do not know which comprehensive gene expression database is more useful for selecting therapeutic targets. It may be that DEGs commonly observed in both the CAGE- and RNA-seq-derived datasets will yield the best targets. Nevertheless, conclusions on this point cannot be drawn until the functional characterization of a number of candidate genes from both groups is completed.</p></sec><sec id="Sec16" sec-type="conclusions"><title>Conclusions</title><p>In summary, CAGE analysis followed by <italic>in silico</italic> molecular network analysis using retinal samples from a mouse ONC model revealed a list of DEGs partly matching a list previously identified with RNA-seq data [<xref ref-type="bibr" rid="CR29">29</xref>]. A detailed analysis of TSSs provided us with a wealth of unique information on the differential use of promoters and the associated DNA binding motifs. As a next step, we aim to develop a high throughput pipeline to enable the efficient prioritization of candidate genes, using the current CAGE dataset to search for novel drug targets.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec17"><supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12864_2014_6671_MOESM1_ESM.tiff"><caption><p>Additional file 1:
<bold>Summary of mapping statistics from SAMStat output.</bold> The pie charts show the number of sequence alignments in various mapping quality (MAPQ) intervals and the number of unmapped sequences. The percentage and number of alignments in each category is given in brackets. Red indicates reads with a high mapping accuracy (MAPQ &#x0003e;&#x02009;30). Black indicates unmapped reads. The RNA integrity number (RIN) of each sample is shown after the sample name. (TIFF 1 MB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12864_2014_6671_MOESM2_ESM.tiff"><caption><p>Additional file 2:
<bold>CAGE data analysis workflow.</bold> The workflow has two phases: primary data processing followed by clustering and analysis. During the first phase, the sequence data is evaluated for quality, filtered, mapped, and converted to an annotation file with a nAnT-iCAGE pipeline. During the second phase, the file is fed into the analytical pipeline, where the analysis of differential expression and motif discovery are carried out with the RECLU pipeline. (TIFF 163 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="12864_2014_6671_MOESM3_ESM.pdf"><caption><p>Additional file 3:
<bold>List of Taqman probes used in this study.</bold>
(PDF 44 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="12864_2014_6671_MOESM4_ESM.xlsx"><caption><p>Additional file 4:
<bold>List of DEGs after ONC.</bold>
(XLSX 65 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="12864_2014_6671_MOESM5_ESM.xlsx"><caption><p>Additional file 5:
<bold>List of unannotated TSS clusters differentially expressed after ONC.</bold>
(XLSX 69 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="12864_2014_6671_MOESM6_ESM.xlsx"><caption><p>Additional file 6:
<bold>List of expression changes in the retinal cell-specific transcriptome.</bold>
(XLSX 50 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="12864_2014_6671_MOESM7_ESM.tiff"><caption><p>Additional file 7:
<bold>Example of top and bottom peaks of TSS clusters.</bold> Genome Explorer views of <italic>Efemp1</italic> and <italic>Eif1</italic> genes are shown here, representing TSS clusters with a top peak (A) and a bottom peak (B), defined with a modified Paraclu program. Based on the distribution of the mapped tags, TSS clusters show two types of structures, sharp with a high peak (termed &#x0201c;top&#x0201d;) and broad with a low peak (termed &#x0201c;bottom&#x0201d;) [<xref ref-type="bibr" rid="CR42">42</xref>]. The red frame indicates a top peak. The blue frame indicates a bottom peak. (TIFF 189 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="12864_2014_6671_MOESM8_ESM.tiff"><caption><p>Additional file 8:
<bold>Alternative promoter usage in</bold>
<bold><italic>Tnfrsf12a</italic></bold>
<bold>gene transcription after ONC.</bold> Genome Explorer view comparing the distribution of mapped CAGE tags for the <italic>Tnfrsf12a</italic> gene in the ONC and sham groups. The X-axis indicates the number of mapped CAGE tags. Alternative promoters of <italic>Tnfrsf12a</italic> were activated at the bottom peak after ONC (red frame). (TIFF 212 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="12864_2014_6671_MOESM9_ESM.xlsx"><caption><p>Additional file 9:
<bold>Detailed list of functions and molecules associated with the &#x0201c;Cell Death and Survival&#x0201d; pathway after ONC.</bold>
(XLSX 51 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="12864_2014_6671_MOESM10_ESM.xlsx"><caption><p>Additional file 10:
<bold>List of DEGs involved in the Cell death and Cell survival pathways after ONC.</bold>
(XLSX 35 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM11"><media xlink:href="12864_2014_6671_MOESM11_ESM.pdf"><caption><p>Additional file 11:
<bold>Predicted regulators of axonal injury after ONC.</bold>
(PDF 46 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM12"><media xlink:href="12864_2014_6671_MOESM12_ESM.tiff"><caption><p>Additional file 12:
<bold>DNA sequence motifs likely to regulate gene expression changes after ONC.</bold> Logos of the most significantly up- or down-regulated DNA sequence motifs for each TSS peak are shown. The relative size of the letters represents their frequency in the motif sequences. (TIFF 150 KB)</p></caption></media></supplementary-material></sec></sec></body><back><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>MY, TN, MR and YT designed and organized this research. MY and YT sampled retinas from the mice. YT and ST prepared total RNA from the samples. MY and YT analyzed the obtained data. MY, KMN, YT, KM, and TN interpreted the results. MY and KMN wrote the manuscript. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was supported in part by JSPS KAKENHI Grants-in-Aid for Scientific Research B (T.N. 26293372) and for Challenging Exploratory Research (Y.T. 26670263 and T.N. 26670751). This study was also supported by the JST Center for Revitalization Promotion (Y.T. and T.N.), Senju Pharmaceutical Co., Ltd. (<ext-link ext-link-type="uri" xlink:href="http://www.senju.co.jp/">http://www.senju.co.jp/</ext-link>), and NIDEK Co., Ltd. (<ext-link ext-link-type="uri" xlink:href="http://www.nidek.co.jp/index-j.html">http://www.nidek.co.jp/index-j.html</ext-link>). This study received additional support from the Great East Japan Earthquake Reconstruction Support Project of the Genome Network Analysis Support Facility (GeNAS) of the RIKEN Center for Life Science Technologies and Illumina K.K. We thank the GeNAS for preparing the CAGE library and performing the sequencing. We thank the Cell Innovation Program (National Institute of Genetics, Japan) for providing the data analysis platform and thank Mr. Norikazu Monma for technical advice regarding the usage of the platform. We also thank Ms. Junko Sato for technical assistance and thank Mr. Tim Hilts for editing this manuscript.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quigley</surname><given-names>HA</given-names></name><name><surname>Broman</surname><given-names>AT</given-names></name></person-group><article-title>The number of people with glaucoma worldwide in 2010 and 2020</article-title><source>Br J Ophthalmol</source><year>2006</year><volume>90</volume><fpage>262</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1136/bjo.2005.081224</pub-id><?supplied-pmid 16488940?><pub-id pub-id-type="pmid">16488940</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pederson</surname><given-names>JE</given-names></name><name><surname>Anderson</surname><given-names>DR</given-names></name></person-group><article-title>The mode of progressive disc cupping in ocular hypertension and glaucoma</article-title><source>Arch Ophthalmol</source><year>1980</year><volume>98</volume><fpage>490</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1001/archopht.1980.01020030486010</pub-id><?supplied-pmid 7362506?><pub-id pub-id-type="pmid">7362506</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heijl</surname><given-names>A</given-names></name><name><surname>Leske</surname><given-names>MC</given-names></name><name><surname>Bengtsson</surname><given-names>B</given-names></name><name><surname>Hyman</surname><given-names>L</given-names></name><name><surname>Bengtsson</surname><given-names>B</given-names></name><name><surname>Hussein</surname><given-names>M</given-names></name></person-group><article-title>Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial</article-title><source>Arch Ophthalmol</source><year>2002</year><volume>120</volume><fpage>1268</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1001/archopht.120.10.1268</pub-id><?supplied-pmid 12365904?><pub-id pub-id-type="pmid">12365904</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Collaborative Normal-Tension Glaucoma Study Group</collab></person-group><article-title>The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma</article-title><source>Am J Ophthalmol</source><year>1998</year><volume>126</volume><fpage>498</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/S0002-9394(98)00272-4</pub-id><pub-id pub-id-type="pmid">9780094</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollands</surname><given-names>H</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Hollands</surname><given-names>S</given-names></name><name><surname>Simel</surname><given-names>DL</given-names></name><name><surname>Jinapriya</surname><given-names>D</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group><article-title>Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review</article-title><source>JAMA</source><year>2013</year><volume>309</volume><fpage>2035</fpage><lpage>2042</lpage><pub-id pub-id-type="doi">10.1001/jama.2013.5099</pub-id><?supplied-pmid 23677315?><pub-id pub-id-type="pmid">23677315</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gugleta</surname><given-names>K</given-names></name><name><surname>Turksever</surname><given-names>C</given-names></name><name><surname>Polunina</surname><given-names>A</given-names></name><name><surname>Orgul</surname><given-names>S</given-names></name></person-group><article-title>Effect of ageing on the retinal vascular responsiveness to flicker light in glaucoma patients and in ocular hypertension</article-title><source>Br J Ophthalmol</source><year>2013</year><volume>97</volume><fpage>848</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2012-302779</pub-id><?supplied-pmid 23624271?><pub-id pub-id-type="pmid">23624271</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgoyne</surname><given-names>CF</given-names></name></person-group><article-title>A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma</article-title><source>Exp Eye Res</source><year>2011</year><volume>93</volume><fpage>120</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2010.09.005</pub-id><?supplied-pmid 20849846?><pub-id pub-id-type="pmid">20849846</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitmore</surname><given-names>AV</given-names></name><name><surname>Libby</surname><given-names>RT</given-names></name><name><surname>John</surname><given-names>SW</given-names></name></person-group><article-title>Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes?</article-title><source>Prog Retin Eye Res</source><year>2005</year><volume>24</volume><fpage>639</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2005.04.004</pub-id><?supplied-pmid 15953750?><pub-id pub-id-type="pmid">15953750</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HY</given-names></name><name><surname>Jeon</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>CK</given-names></name></person-group><article-title>Enhanced depth imaging detects lamina cribrosa thickness differences in normal tension glaucoma and primary open-angle glaucoma</article-title><source>Ophthalmology</source><year>2012</year><volume>119</volume><fpage>10</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2011.07.033</pub-id><?supplied-pmid 22015382?><pub-id pub-id-type="pmid">22015382</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SC</given-names></name><name><surname>Hsu</surname><given-names>AT</given-names></name><name><surname>Su</surname><given-names>D</given-names></name><name><surname>Simonson</surname><given-names>JL</given-names></name><name><surname>Al-Jumayli</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liebmann</surname><given-names>JM</given-names></name><name><surname>Ritch</surname><given-names>R</given-names></name></person-group><article-title>Factors associated with focal lamina cribrosa defects in glaucoma</article-title><source>Invest Ophthalmol Vis Sci</source><year>2013</year><volume>54</volume><fpage>8401</fpage><lpage>8407</lpage><pub-id pub-id-type="doi">10.1167/iovs.13-13014</pub-id><?supplied-pmid 24255039?><pub-id pub-id-type="pmid">24255039</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatham</surname><given-names>AJ</given-names></name><name><surname>Miki</surname><given-names>A</given-names></name><name><surname>Weinreb</surname><given-names>RN</given-names></name><name><surname>Zangwill</surname><given-names>LM</given-names></name><name><surname>Medeiros</surname><given-names>FA</given-names></name></person-group><article-title>Defects of the lamina cribrosa in eyes with localized retinal nerve fiber layer loss</article-title><source>Ophthalmology</source><year>2014</year><volume>121</volume><fpage>110</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2013.08.018</pub-id><?supplied-pmid 24144452?><pub-id pub-id-type="pmid">24144452</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>JE</given-names></name></person-group><article-title>Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage</article-title><source>Eye (Lond)</source><year>2000</year><volume>14</volume><issue>Pt 3B</issue><fpage>437</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1038/eye.2000.128</pub-id><pub-id pub-id-type="pmid">11026971</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quigley</surname><given-names>HA</given-names></name><name><surname>Addicks</surname><given-names>EM</given-names></name><name><surname>Green</surname><given-names>WR</given-names></name><name><surname>Maumenee</surname><given-names>AE</given-names></name></person-group><article-title>Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage</article-title><source>Arch Ophthalmol</source><year>1981</year><volume>99</volume><fpage>635</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1001/archopht.1981.03930010635009</pub-id><?supplied-pmid 6164357?><pub-id pub-id-type="pmid">6164357</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolman</surname><given-names>CL</given-names></name><name><surname>McCormick</surname><given-names>AQ</given-names></name><name><surname>Drance</surname><given-names>SM</given-names></name></person-group><article-title>Aging of the optic nerve</article-title><source>Arch Ophthalmol</source><year>1980</year><volume>98</volume><fpage>2053</fpage><lpage>2058</lpage><pub-id pub-id-type="doi">10.1001/archopht.1980.01020040905024</pub-id><?supplied-pmid 7436843?><pub-id pub-id-type="pmid">7436843</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossniklaus</surname><given-names>HE</given-names></name><name><surname>Nickerson</surname><given-names>JM</given-names></name><name><surname>Edelhauser</surname><given-names>HF</given-names></name><name><surname>Bergman</surname><given-names>LA</given-names></name><name><surname>Berglin</surname><given-names>L</given-names></name></person-group><article-title>Anatomic alterations in aging and age-related diseases of the eye</article-title><source>Invest Ophthalmol Vis Sci</source><year>2013</year><volume>54</volume><fpage>ORSF23</fpage><lpage>ORSF27</lpage><pub-id pub-id-type="doi">10.1167/iovs.13-12711</pub-id><?supplied-pmid 24335063?><pub-id pub-id-type="pmid">24335063</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albon</surname><given-names>J</given-names></name><name><surname>Purslow</surname><given-names>PP</given-names></name><name><surname>Karwatowski</surname><given-names>WS</given-names></name><name><surname>Easty</surname><given-names>DL</given-names></name></person-group><article-title>Age related compliance of the lamina cribrosa in human eyes</article-title><source>Br J Ophthalmol</source><year>2000</year><volume>84</volume><fpage>318</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1136/bjo.84.3.318</pub-id><?supplied-pmid 10684845?><pub-id pub-id-type="pmid">10684845</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotecha</surname><given-names>A</given-names></name><name><surname>Izadi</surname><given-names>S</given-names></name><name><surname>Jeffery</surname><given-names>G</given-names></name></person-group><article-title>Age-related changes in the thickness of the human lamina cribrosa</article-title><source>Br J Ophthalmol</source><year>2006</year><volume>90</volume><fpage>1531</fpage><lpage>1534</lpage><pub-id pub-id-type="doi">10.1136/bjo.2006.100388</pub-id><?supplied-pmid 16943226?><pub-id pub-id-type="pmid">16943226</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orgul</surname><given-names>S</given-names></name><name><surname>Cioffi</surname><given-names>GA</given-names></name><name><surname>Wilson</surname><given-names>DJ</given-names></name><name><surname>Bacon</surname><given-names>DR</given-names></name><name><surname>Van Buskirk</surname><given-names>EM</given-names></name></person-group><article-title>An endothelin-1 induced model of optic nerve ischemia in the rabbit</article-title><source>Invest Ophthalmol Vis Sci</source><year>1996</year><volume>37</volume><fpage>1860</fpage><lpage>1869</lpage><?supplied-pmid 8759355?><pub-id pub-id-type="pmid">8759355</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaratnasingam</surname><given-names>C</given-names></name><name><surname>Morgan</surname><given-names>WH</given-names></name><name><surname>Bass</surname><given-names>L</given-names></name><name><surname>Kang</surname><given-names>M</given-names></name><name><surname>Cringle</surname><given-names>SJ</given-names></name><name><surname>Yu</surname><given-names>DY</given-names></name></person-group><article-title>Time-dependent effects of focal retinal ischemia on axonal cytoskeleton proteins</article-title><source>Invest Ophthalmol Vis Sci</source><year>2010</year><volume>51</volume><fpage>3019</fpage><lpage>3028</lpage><pub-id pub-id-type="doi">10.1167/iovs.09-4692</pub-id><?supplied-pmid 20089877?><pub-id pub-id-type="pmid">20089877</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieck</surname><given-names>J</given-names></name></person-group><article-title>The pathogenesis of glaucoma in the interplay with the immune system</article-title><source>Invest Ophthalmol Vis Sci</source><year>2013</year><volume>54</volume><fpage>2393</fpage><lpage>2409</lpage><pub-id pub-id-type="doi">10.1167/iovs.12-9781</pub-id><?supplied-pmid 23539162?><pub-id pub-id-type="pmid">23539162</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tezel</surname><given-names>G</given-names></name></person-group><article-title>The immune response in glaucoma: a perspective on the roles of oxidative stress</article-title><source>Exp Eye Res</source><year>2011</year><volume>93</volume><fpage>178</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2010.07.009</pub-id><?supplied-pmid 20709058?><pub-id pub-id-type="pmid">20709058</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tezel</surname><given-names>G</given-names></name></person-group><article-title>Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences</article-title><source>Prog Retin Eye Res</source><year>2006</year><volume>25</volume><fpage>490</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2006.07.003</pub-id><?supplied-pmid 16962364?><pub-id pub-id-type="pmid">16962364</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>KY</given-names></name><name><surname>Shim</surname><given-names>MS</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>S</given-names></name><name><surname>Ellisman</surname><given-names>MH</given-names></name><name><surname>Weinreb</surname><given-names>RN</given-names></name><name><surname>Perkins</surname><given-names>GA</given-names></name><name><surname>Ju</surname><given-names>WK</given-names></name></person-group><article-title>Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes</article-title><source>Cell Death Dis</source><year>2013</year><volume>4</volume><fpage>e820</fpage><pub-id pub-id-type="doi">10.1038/cddis.2013.341</pub-id><?supplied-pmid 24091663?><pub-id pub-id-type="pmid">24091663</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinreb</surname><given-names>RN</given-names></name><name><surname>Friedman</surname><given-names>DS</given-names></name><name><surname>Fechtner</surname><given-names>RD</given-names></name><name><surname>Cioffi</surname><given-names>GA</given-names></name><name><surname>Coleman</surname><given-names>AL</given-names></name><name><surname>Girkin</surname><given-names>CA</given-names></name><name><surname>Liebmann</surname><given-names>JM</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Wilson</surname><given-names>MR</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Kannel</surname><given-names>WB</given-names></name></person-group><article-title>Risk assessment in the management of patients with ocular hypertension</article-title><source>Am J Ophthalmol</source><year>2004</year><volume>138</volume><fpage>458</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2004.04.054</pub-id><?supplied-pmid 15364230?><pub-id pub-id-type="pmid">15364230</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>M</given-names></name><name><surname>Yasuda</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name><name><surname>Shanab</surname><given-names>AY</given-names></name><name><surname>Watanabe</surname><given-names>R</given-names></name><name><surname>Himori</surname><given-names>N</given-names></name><name><surname>Omodaka</surname><given-names>K</given-names></name><name><surname>Yokoyama</surname><given-names>Y</given-names></name><name><surname>Takano</surname><given-names>J</given-names></name><name><surname>Saido</surname><given-names>T</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name></person-group><article-title>Critical role of calpain in axonal damage-induced retinal ganglion cell death</article-title><source>J Neurosci Res</source><year>2012</year><volume>90</volume><fpage>802</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1002/jnr.22800</pub-id><?supplied-pmid 22065590?><pub-id pub-id-type="pmid">22065590</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>D</given-names></name><name><surname>Petkova</surname><given-names>V</given-names></name><name><surname>Thanos</surname><given-names>S</given-names></name><name><surname>Benowitz</surname><given-names>LI</given-names></name></person-group><article-title>Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>8726</fpage><lpage>8740</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2774-04.2004</pub-id><?supplied-pmid 15470139?><pub-id pub-id-type="pmid">15470139</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>TA</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Huntwork-Rodriguez</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Eastham-Anderson</surname><given-names>J</given-names></name><name><surname>Modrusan</surname><given-names>Z</given-names></name><name><surname>Kaminker</surname><given-names>JS</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Lewcock</surname><given-names>JW</given-names></name></person-group><article-title>DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury</article-title><source>Proc Natl Acad Sci U S A</source><year>2013</year><volume>110</volume><fpage>4039</fpage><lpage>4044</lpage><pub-id pub-id-type="doi">10.1073/pnas.1211074110</pub-id><?supplied-pmid 23431164?><pub-id pub-id-type="pmid">23431164</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name></person-group><article-title>RNA-Seq: a revolutionary tool for transcriptomics</article-title><source>Nat Rev Genet</source><year>2009</year><volume>10</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/nrg2484</pub-id><?supplied-pmid 19015660?><pub-id pub-id-type="pmid">19015660</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Ryu</surname><given-names>M</given-names></name><name><surname>Tsuda</surname><given-names>S</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name></person-group><article-title>RNA sequence reveals mouse retinal transcriptome changes early after axonal injury</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e93258</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0093258</pub-id><?supplied-pmid 24676137?><pub-id pub-id-type="pmid">24676137</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiraki</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Katayama</surname><given-names>S</given-names></name><name><surname>Waki</surname><given-names>K</given-names></name><name><surname>Kasukawa</surname><given-names>T</given-names></name><name><surname>Kawaji</surname><given-names>H</given-names></name><name><surname>Kodzius</surname><given-names>R</given-names></name><name><surname>Watahiki</surname><given-names>A</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Arakawa</surname><given-names>T</given-names></name><name><surname>Fukuda</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>D</given-names></name><name><surname>Podhajska</surname><given-names>A</given-names></name><name><surname>Harbers</surname><given-names>M</given-names></name><name><surname>Kawai</surname><given-names>J</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name></person-group><article-title>Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage</article-title><source>Proc Natl Acad Sci U S A</source><year>2003</year><volume>100</volume><fpage>15776</fpage><lpage>15781</lpage><pub-id pub-id-type="doi">10.1073/pnas.2136655100</pub-id><?supplied-pmid 14663149?><pub-id pub-id-type="pmid">14663149</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Hoon</surname><given-names>M</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name></person-group><article-title>Deep cap analysis gene expression (CAGE): genome-wide identification of promoters, quantification of their expression, and network inference</article-title><source>Biotechniques</source><year>2008</year><volume>44</volume><fpage>627</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.2144/000112802</pub-id><?supplied-pmid 18474037?><pub-id pub-id-type="pmid">18474037</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoskins</surname><given-names>RA</given-names></name><name><surname>Landolin</surname><given-names>JM</given-names></name><name><surname>Brown</surname><given-names>JB</given-names></name><name><surname>Sandler</surname><given-names>JE</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Lassmann</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Booth</surname><given-names>BW</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Wan</surname><given-names>KH</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Boley</surname><given-names>N</given-names></name><name><surname>Andrews</surname><given-names>J</given-names></name><name><surname>Kaufman</surname><given-names>TC</given-names></name><name><surname>Graveley</surname><given-names>BR</given-names></name><name><surname>Bickel</surname><given-names>PJ</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Carlson</surname><given-names>JW</given-names></name><name><surname>Celniker</surname><given-names>SE</given-names></name></person-group><article-title>Genome-wide analysis of promoter architecture in Drosophila melanogaster</article-title><source>Genome Res</source><year>2011</year><volume>21</volume><fpage>182</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1101/gr.112466.110</pub-id><?supplied-pmid 21177961?><pub-id pub-id-type="pmid">21177961</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Stamatoyannopoulos</surname><given-names>JA</given-names></name><name><surname>Dutta</surname><given-names>A</given-names></name><name><surname>Guigo</surname><given-names>R</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name><name><surname>Margulies</surname><given-names>EH</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name><name><surname>Dermitzakis</surname><given-names>ET</given-names></name><name><surname>Thurman</surname><given-names>RE</given-names></name><name><surname>Kuehn</surname><given-names>MS</given-names></name><name><surname>Taylor</surname><given-names>CM</given-names></name><name><surname>Neph</surname><given-names>S</given-names></name><name><surname>Koch</surname><given-names>CM</given-names></name><name><surname>Asthana</surname><given-names>S</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Adzhubei</surname><given-names>I</given-names></name><name><surname>Greenbaum</surname><given-names>JA</given-names></name><name><surname>Andrews</surname><given-names>RM</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Boyle</surname><given-names>PJ</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Carter</surname><given-names>NP</given-names></name><name><surname>Clelland</surname><given-names>GK</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Day</surname><given-names>N</given-names></name><name><surname>Dhami</surname><given-names>P</given-names></name><name><surname>Dillon</surname><given-names>SC</given-names></name><name><surname>Dorschner</surname><given-names>MO</given-names></name><name><surname>Fiegler</surname><given-names>H</given-names></name><etal/></person-group><article-title>Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project</article-title><source>Nature</source><year>2007</year><volume>447</volume><fpage>799</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1038/nature05874</pub-id><?supplied-pmid 17571346?><pub-id pub-id-type="pmid">17571346</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Dunham</surname><given-names>I</given-names></name><name><surname>Green</surname><given-names>ED</given-names></name><name><surname>Gunter</surname><given-names>C</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name></person-group><article-title>An integrated encyclopedia of DNA elements in the human genome</article-title><source>Nature</source><year>2012</year><volume>489</volume><fpage>57</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature11247</pub-id><pub-id pub-id-type="pmid">22955616</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allcutt</surname><given-names>D</given-names></name><name><surname>Berry</surname><given-names>M</given-names></name><name><surname>Sievers</surname><given-names>J</given-names></name></person-group><article-title>A qualitative comparison of the reactions of retinal ganglion cell axons to optic nerve crush in neonatal and adult mice</article-title><source>Brain Res</source><year>1984</year><volume>318</volume><fpage>231</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/0165-3806(84)90028-2</pub-id><?supplied-pmid 6498499?><pub-id pub-id-type="pmid">6498499</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanamori-Katayama</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Kawaji</surname><given-names>H</given-names></name><name><surname>Lassmann</surname><given-names>T</given-names></name><name><surname>Katayama</surname><given-names>S</given-names></name><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Bertin</surname><given-names>N</given-names></name><name><surname>Kaiho</surname><given-names>A</given-names></name><name><surname>Ninomiya</surname><given-names>N</given-names></name><name><surname>Daub</surname><given-names>CO</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Forrest</surname><given-names>AR</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name></person-group><article-title>Unamplified cap analysis of gene expression on a single-molecule sequencer</article-title><source>Genome Res</source><year>2011</year><volume>21</volume><fpage>1150</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1101/gr.115469.110</pub-id><?supplied-pmid 21596820?><pub-id pub-id-type="pmid">21596820</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Lassmann</surname><given-names>T</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name></person-group><article-title>5&#x02032; end-centered expression profiling using cap-analysis gene expression and next-generation sequencing</article-title><source>Nat Protoc</source><year>2012</year><volume>7</volume><fpage>542</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.005</pub-id><?supplied-pmid 22362160?><pub-id pub-id-type="pmid">22362160</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Nishiyori-Sueki</surname><given-names>H</given-names></name><name><surname>Kojima-Ishiyama</surname><given-names>M</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name></person-group><article-title>Detecting expressed genes using CAGE</article-title><source>Methods Mol Biol</source><year>2014</year><volume>1164</volume><fpage>67</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-0805-9_7</pub-id><?supplied-pmid 24927836?><pub-id pub-id-type="pmid">24927836</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name></person-group><article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>1754</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id><?supplied-pmid 19451168?><pub-id pub-id-type="pmid">19451168</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Handsaker</surname><given-names>B</given-names></name><name><surname>Wysoker</surname><given-names>A</given-names></name><name><surname>Fennell</surname><given-names>T</given-names></name><name><surname>Ruan</surname><given-names>J</given-names></name><name><surname>Homer</surname><given-names>N</given-names></name><name><surname>Marth</surname><given-names>G</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name></person-group><article-title>The sequence alignment/Map format and SAMtools</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><?supplied-pmid 19505943?><pub-id pub-id-type="pmid">19505943</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassmann</surname><given-names>T</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Daub</surname><given-names>CO</given-names></name></person-group><article-title>SAMStat: monitoring biases in next generation sequencing data</article-title><source>Bioinformatics</source><year>2011</year><volume>27</volume><fpage>130</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq614</pub-id><?supplied-pmid 21088025?><pub-id pub-id-type="pmid">21088025</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohmiya</surname><given-names>H</given-names></name><name><surname>Vitezic</surname><given-names>M</given-names></name><name><surname>Frith</surname><given-names>MC</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Forrest</surname><given-names>AR</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Lassmann</surname><given-names>T</given-names></name></person-group><article-title>RECLU: a pipeline to discover reproducible transcriptional start sites and their alternative regulation using capped analysis of gene expression (CAGE)</article-title><source>BMC Genomics</source><year>2014</year><volume>15</volume><fpage>269</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-15-269</pub-id><?supplied-pmid 24779366?><pub-id pub-id-type="pmid">24779366</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frith</surname><given-names>MC</given-names></name><name><surname>Valen</surname><given-names>E</given-names></name><name><surname>Krogh</surname><given-names>A</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Sandelin</surname><given-names>A</given-names></name></person-group><article-title>A code for transcription initiation in mammalian genomes</article-title><source>Genome Res</source><year>2008</year><volume>18</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1101/gr.6831208</pub-id><?supplied-pmid 18032727?><pub-id pub-id-type="pmid">18032727</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Brown</surname><given-names>JB</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Bickel</surname><given-names>PJ</given-names></name></person-group><article-title>Measuring reproducibility of high-throughput experiments</article-title><source>Annals Appl Stat</source><year>2011</year><volume>5</volume><fpage>1752</fpage><lpage>1779</lpage><pub-id pub-id-type="doi">10.1214/11-AOAS466</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzzo</surname><given-names>WL</given-names></name><name><surname>Tompa</surname><given-names>M</given-names></name></person-group><article-title>A linear time algorithm for finding all maximal scoring subsequences</article-title><source>Proc Int Conf Intell Syst Mol Biol</source><year>1999</year><volume>7</volume><fpage>234</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">10786306</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name></person-group><article-title>AMD, an automated motif discovery tool using stepwise refinement of gapped consensuses</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e24576</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0024576</pub-id><?supplied-pmid 21931761?><pub-id pub-id-type="pmid">21931761</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frith</surname><given-names>MC</given-names></name><name><surname>Saunders</surname><given-names>NF</given-names></name><name><surname>Kobe</surname><given-names>B</given-names></name><name><surname>Bailey</surname><given-names>TL</given-names></name></person-group><article-title>Discovering sequence motifs with arbitrary insertions and deletions</article-title><source>PLoS Comput Biol</source><year>2008</year><volume>4</volume><fpage>e1000071</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1000071</pub-id><?supplied-pmid 18437229?><pub-id pub-id-type="pmid">18437229</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavesi</surname><given-names>G</given-names></name><name><surname>Mereghetti</surname><given-names>P</given-names></name><name><surname>Mauri</surname><given-names>G</given-names></name><name><surname>Pesole</surname><given-names>G</given-names></name></person-group><article-title>Weeder Web: discovery of transcription factor binding sites in a set of sequences from co-regulated genes</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><fpage>W199</fpage><lpage>W203</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh465</pub-id><?supplied-pmid 15215380?><pub-id pub-id-type="pmid">15215380</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>TL</given-names></name></person-group><article-title>DREME: motif discovery in transcription factor ChIP-seq data</article-title><source>Bioinformatics</source><year>2011</year><volume>27</volume><fpage>1653</fpage><lpage>1659</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr261</pub-id><?supplied-pmid 21543442?><pub-id pub-id-type="pmid">21543442</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>TL</given-names></name><name><surname>Boden</surname><given-names>M</given-names></name><name><surname>Buske</surname><given-names>FA</given-names></name><name><surname>Frith</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>CE</given-names></name><name><surname>Clementi</surname><given-names>L</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>WW</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name></person-group><article-title>MEME SUITE: tools for motif discovery and searching</article-title><source>Nucleic Acids Res</source><year>2009</year><volume>37</volume><fpage>W202</fpage><lpage>W208</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp335</pub-id><?supplied-pmid 19458158?><pub-id pub-id-type="pmid">19458158</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathelier</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>AW</given-names></name><name><surname>Parcy</surname><given-names>F</given-names></name><name><surname>Worsley-Hunt</surname><given-names>R</given-names></name><name><surname>Arenillas</surname><given-names>DJ</given-names></name><name><surname>Buchman</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Chou</surname><given-names>A</given-names></name><name><surname>Ienasescu</surname><given-names>H</given-names></name><name><surname>Lim</surname><given-names>J</given-names></name><name><surname>Shyr</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Lenhard</surname><given-names>B</given-names></name><name><surname>Sandelin</surname><given-names>A</given-names></name><name><surname>Wasserman</surname><given-names>WW</given-names></name></person-group><article-title>JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>D142</fpage><lpage>D147</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt997</pub-id><?supplied-pmid 24194598?><pub-id pub-id-type="pmid">24194598</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanab</surname><given-names>AY</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name><name><surname>Ryu</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Himori</surname><given-names>N</given-names></name><name><surname>Taguchi</surname><given-names>K</given-names></name><name><surname>Yasuda</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>R</given-names></name><name><surname>Takano</surname><given-names>J</given-names></name><name><surname>Saido</surname><given-names>T</given-names></name><name><surname>Minegishi</surname><given-names>N</given-names></name><name><surname>Miyata</surname><given-names>T</given-names></name><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Metabolic stress response implicated in diabetic retinopathy: the role of calpain, and the therapeutic impact of calpain inhibitor</article-title><source>Neurobiol Dis</source><year>2012</year><volume>48</volume><fpage>556</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2012.07.025</pub-id><?supplied-pmid 22967911?><pub-id pub-id-type="pmid">22967911</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prat-Vidal</surname><given-names>C</given-names></name><name><surname>Galvez-Monton</surname><given-names>C</given-names></name><name><surname>Nonell</surname><given-names>L</given-names></name><name><surname>Puigdecanet</surname><given-names>E</given-names></name><name><surname>Astier</surname><given-names>L</given-names></name><name><surname>Sole</surname><given-names>F</given-names></name><name><surname>Bayes-Genis</surname><given-names>A</given-names></name></person-group><article-title>Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e54785</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0054785</pub-id><?supplied-pmid 23372767?><pub-id pub-id-type="pmid">23372767</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saili</surname><given-names>KS</given-names></name><name><surname>Tilton</surname><given-names>SC</given-names></name><name><surname>Waters</surname><given-names>KM</given-names></name><name><surname>Tanguay</surname><given-names>RL</given-names></name></person-group><article-title>Global gene expression analysis reveals pathway differences between teratogenic and non-teratogenic exposure concentrations of bisphenol A and 17beta-estradiol in embryonic zebrafish</article-title><source>Reprod Toxicol</source><year>2013</year><volume>38</volume><fpage>89</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.reprotox.2013.03.009</pub-id><?supplied-pmid 23557687?><pub-id pub-id-type="pmid">23557687</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassone</surname><given-names>CG</given-names></name><name><surname>Taylor</surname><given-names>JJ</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>JM</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Yauk</surname><given-names>CL</given-names></name><name><surname>Crump</surname><given-names>D</given-names></name><name><surname>Kennedy</surname><given-names>SW</given-names></name></person-group><article-title>Transcriptional profiles in the cerebral hemisphere of chicken embryos following in ovo perfluorohexane sulfonate exposure</article-title><source>Toxicol Sci</source><year>2012</year><volume>129</volume><fpage>380</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfs219</pub-id><?supplied-pmid 22790973?><pub-id pub-id-type="pmid">22790973</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">R Core Team: <italic>R: A Language and Environment for Statistical Computing</italic>. Austria: R Foundation for Statistical Computing V; Available: <ext-link ext-link-type="uri" xlink:href="http://www.R-project.org">http://www.R-project.org</ext-link></mixed-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaji</surname><given-names>H</given-names></name><name><surname>Lizio</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Kanamori-Katayama</surname><given-names>M</given-names></name><name><surname>Kaiho</surname><given-names>A</given-names></name><name><surname>Nishiyori-Sueki</surname><given-names>H</given-names></name><name><surname>Shin</surname><given-names>JW</given-names></name><name><surname>Kojima-Ishiyama</surname><given-names>M</given-names></name><name><surname>Kawano</surname><given-names>M</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Ninomiya-Fukuda</surname><given-names>N</given-names></name><name><surname>Ishikawa-Kato</surname><given-names>S</given-names></name><name><surname>Nagao-Sato</surname><given-names>S</given-names></name><name><surname>Noma</surname><given-names>S</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Forrest</surname><given-names>AR</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name></person-group><article-title>Comparison of CAGE and RNA-seq transcriptome profiling using clonally amplified and single-molecule next-generation sequencing</article-title><source>Genome Res</source><year>2014</year><volume>24</volume><fpage>708</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1101/gr.156232.113</pub-id><?supplied-pmid 24676093?><pub-id pub-id-type="pmid">24676093</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegert</surname><given-names>S</given-names></name><name><surname>Cabuy</surname><given-names>E</given-names></name><name><surname>Scherf</surname><given-names>BG</given-names></name><name><surname>Kohler</surname><given-names>H</given-names></name><name><surname>Panda</surname><given-names>S</given-names></name><name><surname>Le</surname><given-names>YZ</given-names></name><name><surname>Fehling</surname><given-names>HJ</given-names></name><name><surname>Gaidatzis</surname><given-names>D</given-names></name><name><surname>Stadler</surname><given-names>MB</given-names></name><name><surname>Roska</surname><given-names>B</given-names></name></person-group><article-title>Transcriptional code and disease map for adult retinal cell types</article-title><source>Nat Neurosci</source><year>2012</year><volume>15</volume><fpage>487</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1038/nn.3032</pub-id><?supplied-pmid 22267162?><pub-id pub-id-type="pmid">22267162</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadal-Nicolas</surname><given-names>FM</given-names></name><name><surname>Jimenez-Lopez</surname><given-names>M</given-names></name><name><surname>Sobrado-Calvo</surname><given-names>P</given-names></name><name><surname>Nieto-Lopez</surname><given-names>L</given-names></name><name><surname>Canovas-Martinez</surname><given-names>I</given-names></name><name><surname>Salinas-Navarro</surname><given-names>M</given-names></name><name><surname>Vidal-Sanz</surname><given-names>M</given-names></name><name><surname>Agudo</surname><given-names>M</given-names></name></person-group><article-title>Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas</article-title><source>Invest Ophthalmol Vis Sci</source><year>2009</year><volume>50</volume><fpage>3860</fpage><lpage>3868</lpage><pub-id pub-id-type="doi">10.1167/iovs.08-3267</pub-id><?supplied-pmid 19264888?><pub-id pub-id-type="pmid">19264888</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chidlow</surname><given-names>G</given-names></name><name><surname>Casson</surname><given-names>R</given-names></name><name><surname>Sobrado-Calvo</surname><given-names>P</given-names></name><name><surname>Vidal-Sanz</surname><given-names>M</given-names></name><name><surname>Osborne</surname><given-names>NN</given-names></name></person-group><article-title>Measurement of retinal injury in the rat after optic nerve transection: an RT-PCR study</article-title><source>Mol Vis</source><year>2005</year><volume>11</volume><fpage>387</fpage><lpage>396</lpage><?supplied-pmid 15947739?><pub-id pub-id-type="pmid">15947739</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandelin</surname><given-names>A</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Lenhard</surname><given-names>B</given-names></name><name><surname>Ponjavic</surname><given-names>J</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Hume</surname><given-names>DA</given-names></name></person-group><article-title>Mammalian RNA polymerase II core promoters: insights from genome-wide studies</article-title><source>Nat Rev Genet</source><year>2007</year><volume>8</volume><fpage>424</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1038/nrg2026</pub-id><?supplied-pmid 17486122?><pub-id pub-id-type="pmid">17486122</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Severin</surname><given-names>J</given-names></name><name><surname>Lizio</surname><given-names>M</given-names></name><name><surname>Harshbarger</surname><given-names>J</given-names></name><name><surname>Kawaji</surname><given-names>H</given-names></name><name><surname>Daub</surname><given-names>CO</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Bertin</surname><given-names>N</given-names></name><name><surname>Forrest</surname><given-names>AR</given-names></name></person-group><article-title>Interactive visualization and analysis of large-scale sequencing datasets using ZENBU</article-title><source>Nat Biotechnol</source><year>2014</year><volume>32</volume><fpage>217</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1038/nbt.2840</pub-id><?supplied-pmid 24727769?><pub-id pub-id-type="pmid">24727769</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>AR</given-names></name><name><surname>Kawaji</surname><given-names>H</given-names></name><name><surname>Rehli</surname><given-names>M</given-names></name><name><surname>Baillie</surname><given-names>JK</given-names></name><name><surname>de Hoon</surname><given-names>MJ</given-names></name><name><surname>Lassmann</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Summers</surname><given-names>KM</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Daub</surname><given-names>CO</given-names></name><name><surname>Kawai</surname><given-names>J</given-names></name><name><surname>Heutink</surname><given-names>P</given-names></name><name><surname>Hide</surname><given-names>W</given-names></name><name><surname>Freeman</surname><given-names>TC</given-names></name><name><surname>Lenhard</surname><given-names>B</given-names></name><name><surname>Bajic</surname><given-names>VB</given-names></name><name><surname>Taylor</surname><given-names>MS</given-names></name><name><surname>Makeev</surname><given-names>VJ</given-names></name><name><surname>Sandelin</surname><given-names>A</given-names></name><name><surname>Hume</surname><given-names>DA</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name></person-group><article-title>A promoter-level mammalian expression atlas</article-title><source>Nature</source><year>2014</year><volume>507</volume><fpage>462</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1038/nature13182</pub-id><?supplied-pmid 24670764?><pub-id pub-id-type="pmid">24670764</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>SH</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>McGrath</surname><given-names>BC</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Cavener</surname><given-names>DR</given-names></name></person-group><article-title>PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis</article-title><source>Biochem J</source><year>2006</year><volume>393</volume><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1042/BJ20050374</pub-id><?supplied-pmid 16124869?><pub-id pub-id-type="pmid">16124869</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logue</surname><given-names>SE</given-names></name><name><surname>Cleary</surname><given-names>P</given-names></name><name><surname>Saveljeva</surname><given-names>S</given-names></name><name><surname>Samali</surname><given-names>A</given-names></name></person-group><article-title>New directions in ER stress-induced cell death</article-title><source>Apoptosis</source><year>2013</year><volume>18</volume><fpage>537</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1007/s10495-013-0818-6</pub-id><?supplied-pmid 23430059?><pub-id pub-id-type="pmid">23430059</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Flemington</surname><given-names>C</given-names></name><name><surname>Houghton</surname><given-names>AB</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Zambetti</surname><given-names>GP</given-names></name><name><surname>Lutz</surname><given-names>RJ</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Chittenden</surname><given-names>T</given-names></name></person-group><article-title>Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>11318</fpage><lpage>11323</lpage><pub-id pub-id-type="doi">10.1073/pnas.201208798</pub-id><?supplied-pmid 11572983?><pub-id pub-id-type="pmid">11572983</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merry</surname><given-names>DE</given-names></name><name><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Bcl-2 gene family in the nervous system</article-title><source>Annu Rev Neurosci</source><year>1997</year><volume>20</volume><fpage>245</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.20.1.245</pub-id><?supplied-pmid 9056714?><pub-id pub-id-type="pmid">9056714</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Nguyen</surname><given-names>JL</given-names></name><name><surname>Hulleman</surname><given-names>JD</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Rochet</surname><given-names>JC</given-names></name></person-group><article-title>Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson&#x02019;s disease</article-title><source>J Neurochem</source><year>2008</year><volume>105</volume><fpage>2435</fpage><lpage>2453</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05333.x</pub-id><?supplied-pmid 18331584?><pub-id pub-id-type="pmid">18331584</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Barnstable</surname><given-names>CJ</given-names></name></person-group><article-title>PEDF: a multifaceted neurotrophic factor</article-title><source>Nat Rev Neurosci</source><year>2003</year><volume>4</volume><fpage>628</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1038/nrn1176</pub-id><?supplied-pmid 12894238?><pub-id pub-id-type="pmid">12894238</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barabasi</surname><given-names>AL</given-names></name><name><surname>Oltvai</surname><given-names>ZN</given-names></name></person-group><article-title>Network biology: understanding the cell&#x02019;s functional organization</article-title><source>Nat Rev Genet</source><year>2004</year><volume>5</volume><fpage>101</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/nrg1272</pub-id><?supplied-pmid 14735121?><pub-id pub-id-type="pmid">14735121</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bringmann</surname><given-names>A</given-names></name><name><surname>Iandiev</surname><given-names>I</given-names></name><name><surname>Pannicke</surname><given-names>T</given-names></name><name><surname>Wurm</surname><given-names>A</given-names></name><name><surname>Hollborn</surname><given-names>M</given-names></name><name><surname>Wiedemann</surname><given-names>P</given-names></name><name><surname>Osborne</surname><given-names>NN</given-names></name><name><surname>Reichenbach</surname><given-names>A</given-names></name></person-group><article-title>Cellular signaling and factors involved in Muller cell gliosis: neuroprotective and detrimental effects</article-title><source>Prog Retin Eye Res</source><year>2009</year><volume>28</volume><fpage>423</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2009.07.001</pub-id><?supplied-pmid 19660572?><pub-id pub-id-type="pmid">19660572</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galindo-Romero</surname><given-names>C</given-names></name><name><surname>Valiente-Soriano</surname><given-names>FJ</given-names></name><name><surname>Jimenez-Lopez</surname><given-names>M</given-names></name><name><surname>Garcia-Ayuso</surname><given-names>D</given-names></name><name><surname>Villegas-Perez</surname><given-names>MP</given-names></name><name><surname>Vidal-Sanz</surname><given-names>M</given-names></name><name><surname>Agudo-Barriuso</surname><given-names>M</given-names></name></person-group><article-title>Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia</article-title><source>Invest Ophthalmol Vis Sci</source><year>2013</year><volume>54</volume><fpage>974</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1167/iovs.12-11207</pub-id><?supplied-pmid 23307961?><pub-id pub-id-type="pmid">23307961</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milton</surname><given-names>RH</given-names></name><name><surname>Abeti</surname><given-names>R</given-names></name><name><surname>Averaimo</surname><given-names>S</given-names></name><name><surname>DeBiasi</surname><given-names>S</given-names></name><name><surname>Vitellaro</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Curmi</surname><given-names>PM</given-names></name><name><surname>Breit</surname><given-names>SN</given-names></name><name><surname>Duchen</surname><given-names>MR</given-names></name><name><surname>Mazzanti</surname><given-names>M</given-names></name></person-group><article-title>CLIC1 function is required for beta-amyloid-induced generation of reactive oxygen species by microglia</article-title><source>J Neurosci</source><year>2008</year><volume>28</volume><fpage>11488</fpage><lpage>11499</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2431-08.2008</pub-id><?supplied-pmid 18987185?><pub-id pub-id-type="pmid">18987185</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Himori</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Maruyama</surname><given-names>K</given-names></name><name><surname>Ryu</surname><given-names>M</given-names></name><name><surname>Taguchi</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Nakazawa</surname><given-names>T</given-names></name></person-group><article-title>Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death</article-title><source>J Neurochem</source><year>2013</year><volume>127</volume><fpage>669</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1111/jnc.12325</pub-id><?supplied-pmid 23721546?><pub-id pub-id-type="pmid">23721546</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Bian</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Su</surname><given-names>B</given-names></name></person-group><article-title>Microglial TIR-domain-containing adapter-inducing interferon-beta (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-kappaB</article-title><source>J Neuroinflammation</source><year>2012</year><volume>9</volume><fpage>39</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-9-39</pub-id><?supplied-pmid 22361049?><pub-id pub-id-type="pmid">22361049</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eden</surname><given-names>A</given-names></name><name><surname>Benvenisty</surname><given-names>N</given-names></name></person-group><article-title>Involvement of branched-chain amino acid aminotransferase (Bcat1/Eca39) in apoptosis</article-title><source>FEBS Lett</source><year>1999</year><volume>457</volume><fpage>255</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(99)01054-6</pub-id><?supplied-pmid 10471790?><pub-id pub-id-type="pmid">10471790</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galehdar</surname><given-names>Z</given-names></name><name><surname>Swan</surname><given-names>P</given-names></name><name><surname>Fuerth</surname><given-names>B</given-names></name><name><surname>Callaghan</surname><given-names>SM</given-names></name><name><surname>Park</surname><given-names>DS</given-names></name><name><surname>Cregan</surname><given-names>SP</given-names></name></person-group><article-title>Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA</article-title><source>J Neurosci</source><year>2010</year><volume>30</volume><fpage>16938</fpage><lpage>16948</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1598-10.2010</pub-id><?supplied-pmid 21159964?><pub-id pub-id-type="pmid">21159964</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leaver</surname><given-names>SG</given-names></name><name><surname>Cui</surname><given-names>Q</given-names></name><name><surname>Bernard</surname><given-names>O</given-names></name><name><surname>Harvey</surname><given-names>AR</given-names></name></person-group><article-title>Cooperative effects of bcl-2 and AAV-mediated expression of CNTF on retinal ganglion cell survival and axonal regeneration in adult transgenic mice</article-title><source>Eur J Neurosci</source><year>2006</year><volume>24</volume><fpage>3323</fpage><lpage>3332</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.05230.x</pub-id><?supplied-pmid 17229081?><pub-id pub-id-type="pmid">17229081</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>M</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Yonemitsu</surname><given-names>Y</given-names></name><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Murakami</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>N</given-names></name><name><surname>Tabata</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Tobimatsu</surname><given-names>S</given-names></name><name><surname>Sueishi</surname><given-names>K</given-names></name><name><surname>Ishibashi</surname><given-names>T</given-names></name></person-group><article-title>Pigment epithelium-derived factor gene therapy targeting retinal ganglion cell injuries: neuroprotection against loss of function in two animal models</article-title><source>Hum Gene Ther</source><year>2011</year><volume>22</volume><fpage>559</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1089/hum.2010.132</pub-id><?supplied-pmid 21175295?><pub-id pub-id-type="pmid">21175295</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magharious</surname><given-names>M</given-names></name><name><surname>D&#x02019;Onofrio</surname><given-names>PM</given-names></name><name><surname>Hollander</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Koeberle</surname><given-names>PD</given-names></name></person-group><article-title>Quantitative iTRAQ analysis of retinal ganglion cell degeneration after optic nerve crush</article-title><source>J Proteome Res</source><year>2011</year><volume>10</volume><fpage>3344</fpage><lpage>3362</lpage><pub-id pub-id-type="doi">10.1021/pr2004055</pub-id><?supplied-pmid 21627321?><pub-id pub-id-type="pmid">21627321</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonifati</surname><given-names>V</given-names></name><name><surname>Rizzu</surname><given-names>P</given-names></name><name><surname>van Baren</surname><given-names>MJ</given-names></name><name><surname>Schaap</surname><given-names>O</given-names></name><name><surname>Breedveld</surname><given-names>GJ</given-names></name><name><surname>Krieger</surname><given-names>E</given-names></name><name><surname>Dekker</surname><given-names>MC</given-names></name><name><surname>Squitieri</surname><given-names>F</given-names></name><name><surname>Ibanez</surname><given-names>P</given-names></name><name><surname>Joosse</surname><given-names>M</given-names></name><name><surname>van Dongen</surname><given-names>JW</given-names></name><name><surname>Vanacore</surname><given-names>N</given-names></name><name><surname>van Swieten</surname><given-names>JC</given-names></name><name><surname>Brice</surname><given-names>A</given-names></name><name><surname>Meco</surname><given-names>G</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>Oostra</surname><given-names>BA</given-names></name><name><surname>Heutink</surname><given-names>P</given-names></name></person-group><article-title>Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism</article-title><source>Science</source><year>2003</year><volume>299</volume><fpage>256</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1126/science.1077209</pub-id><?supplied-pmid 12446870?><pub-id pub-id-type="pmid">12446870</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahle</surname><given-names>PJ</given-names></name><name><surname>Waak</surname><given-names>J</given-names></name><name><surname>Gasser</surname><given-names>T</given-names></name></person-group><article-title>DJ-1 and prevention of oxidative stress in Parkinson&#x02019;s disease and other age-related disorders</article-title><source>Free Radic Biol Med</source><year>2009</year><volume>47</volume><fpage>1354</fpage><lpage>1361</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.08.003</pub-id><?supplied-pmid 19686841?><pub-id pub-id-type="pmid">19686841</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>I</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Reed</surname><given-names>JC</given-names></name></person-group><article-title>Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities</article-title><source>Nat Rev Drug Discov</source><year>2008</year><volume>7</volume><fpage>1013</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1038/nrd2755</pub-id><?supplied-pmid 19043451?><pub-id pub-id-type="pmid">19043451</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katome</surname><given-names>T</given-names></name><name><surname>Namekata</surname><given-names>K</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Semba</surname><given-names>K</given-names></name><name><surname>Kittaka</surname><given-names>D</given-names></name><name><surname>Kawamura</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Harada</surname><given-names>C</given-names></name><name><surname>Ichijo</surname><given-names>H</given-names></name><name><surname>Mitamura</surname><given-names>Y</given-names></name><name><surname>Harada</surname><given-names>T</given-names></name></person-group><article-title>Inhibition of ASK1-p38 pathway prevents neural cell death following optic nerve injury</article-title><source>Cell Death Differ</source><year>2013</year><volume>20</volume><fpage>270</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/cdd.2012.122</pub-id><?supplied-pmid 22976835?><pub-id pub-id-type="pmid">22976835</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>KK</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Smith</surname><given-names>PD</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Connolly</surname><given-names>L</given-names></name><name><surname>Kramvis</surname><given-names>I</given-names></name><name><surname>Sahin</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>Z</given-names></name></person-group><article-title>Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway</article-title><source>Science</source><year>2008</year><volume>322</volume><fpage>963</fpage><lpage>966</lpage><pub-id pub-id-type="doi">10.1126/science.1161566</pub-id><?supplied-pmid 18988856?><pub-id pub-id-type="pmid">18988856</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deniaud</surname><given-names>E</given-names></name><name><surname>Baguet</surname><given-names>J</given-names></name><name><surname>Mathieu</surname><given-names>AL</given-names></name><name><surname>Pages</surname><given-names>G</given-names></name><name><surname>Marvel</surname><given-names>J</given-names></name><name><surname>Leverrier</surname><given-names>Y</given-names></name></person-group><article-title>Overexpression of Sp1 transcription factor induces apoptosis</article-title><source>Oncogene</source><year>2006</year><volume>25</volume><fpage>7096</fpage><lpage>7105</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1209696</pub-id><?supplied-pmid 16715126?><pub-id pub-id-type="pmid">16715126</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koutsodontis</surname><given-names>G</given-names></name><name><surname>Tentes</surname><given-names>I</given-names></name><name><surname>Papakosta</surname><given-names>P</given-names></name><name><surname>Moustakas</surname><given-names>A</given-names></name><name><surname>Kardassis</surname><given-names>D</given-names></name></person-group><article-title>Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>29116</fpage><lpage>29125</lpage><pub-id pub-id-type="doi">10.1074/jbc.M104130200</pub-id><?supplied-pmid 11384995?><pub-id pub-id-type="pmid">11384995</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiryu-Seo</surname><given-names>S</given-names></name><name><surname>Kato</surname><given-names>R</given-names></name><name><surname>Ogawa</surname><given-names>T</given-names></name><name><surname>Nakagomi</surname><given-names>S</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><name><surname>Kiyama</surname><given-names>H</given-names></name></person-group><article-title>Neuronal injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 through the interaction with Sp1 in damaged neurons</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>6988</fpage><lpage>6996</lpage><pub-id pub-id-type="doi">10.1074/jbc.M707514200</pub-id><?supplied-pmid 18192274?><pub-id pub-id-type="pmid">18192274</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiryu-Seo</surname><given-names>S</given-names></name></person-group><article-title>Identification and functional analysis of damage-induced neuronal endopeptidase (DINE), a nerve injury associated molecule</article-title><source>Anat Sci Int</source><year>2006</year><volume>81</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/j.1447-073X.2006.00136.x</pub-id><?supplied-pmid 16526590?><pub-id pub-id-type="pmid">16526590</pub-id></element-citation></ref></ref-list></back></article>